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dysentery (AD) and amoebic liver abscess (ALA) are endemic in 
the Natal coastal area, including the peri-urban areas of 
Durban. A definitive diagnosis of invasive amoebiasis relies 
on the demonstration of the causative organism, Entamoeba 
histolytica, in either stool specimens in the case of AD or 
the liver aspirate in ALA. While this is relatively simple 
in the case of AD, it is much more difficult in patients with 
ALA. However, the demonstration of specific antibodies to h 
histolytica in serological tests has proved to be useful in 
establishing tissue invasion by the parasite, but these tests 
do not adequately distinguish between specific circulating 
antibodies produced during active amoebic infection and those 
persisting after previous infection, the indirect fluorescent 
antibody test (IFAT) is an exception. Although the IFAT was 
shown to be useful in differentiating between past and 
present infection by monitoring specific IgM-anti-h histo­
lytica antibodies, the test has had limited use in the 
diagnostic laboratory. Therefore, an enzyme-linked immuno­
sorbent assay (ELISA) was evaluated. Most ELISAs have meas­
ured either IgG-anti-lL._ histolytica antibodies or total 
ii. 
immunoglobulins. In this dissertation the ELISA was eval-
uated for its ability to distinguish between past and current 
amoebic infection by detecting specific IgG- and IgM-anti-h 
histolytica antibodies. 
Using a soluble antigen of h histolytica, the ELISA was 
compared with the amoebic gel diffusion test (AGDT). In 100 
patients with clinically diagnosed ALA and 144 controls, the 
IgG-ELISA had a sensitivity of 99% (99/100) and a specificity 
of 91,7% (132/144). In these same patients, the IgM-ELISA had 
a sensitivity of 64% and a specificity of 97,9%. There was an 
excellent correlation between the AGDT and IgG-ELISA (r = 
0,99). 
Although the IgM-ELISA was specific (97,9%), it was not 
sensitive enough (64%) to differentiate between past and 
current amoebic infection. This prompted another study in 
which the ELISA was compared to the AGDT and the IFAT. The 
IFAT is a useful test in diagnosing invasive amoebiasis, but 
the interpretation of immunofluorescence, especially IgM, 
was subjective. 
To improve the diagnostic potential of the IgM-ELISA, the 
plasma membrane of axenic cultures of h histolytica strain 
HK9 was used as the antigen to detect specific IgG and IgM 
iii. 
antibodies. The sensitivities of the IgM- and IgG-ELISA 
in 22 ALA patients were 91% (20/22) and 95% (21/22), respect­
ively. In 22 controls without invasive amoebiasis the spec­
ificities of the IgM- and IgG-ELISA were 95% (21/22) and 91% 
(20/22), respectively. There was an excellent correlation 
(r = 0,96) between the IgG-ELISA and the AGDT. 
The use of the plasma membrane antigen improved the diagnos­
tic potential of the IgM-ELISA in differenting between past 
and current amoebic infection. 
iv. 
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]h histolytica is a protozoan parasite. Amoebiasis has 
been defined as 'the state of an individual harbouring 
]h histolytica' (WHO, 1969). Although the parasite 
usually behaves as a commensal and induces no signs or 
symptoms in the majority, it can result in invasive 
amoebiasis in some (Walsh, 1986). Invasive amoebiasis 
is characterised either by amoebic dysentery or extra­
intestinal lesions (mainly ALA); the latter occurs when 
there is blood-borne dissemination of the amoebae 
(Manson-Bahr and Apted, 1982). The reason why certain 
individuals or communities are more susceptible to 
invasive amoebiasis is not known. Some researchers 
believe that all h histolytica strains are potentially 
capable of invasion .but are usually restrained by host­
mediated defence mechanisms (WHO, 1969). Others feel 
that there are two distinct species of h histolytica 
(Editorial, 1979); one of which is always invasive 
and the other a harmless commensal; these two strains 
can be distinguished by characteristic isoenzyme 
(pathogenic and non-pathogenic zymodemes) patterns 
(Sargeaunt et al, 1978). 
2. 
The protozoan has cystic and 
cysts (10-20um in size) are 
and indicate the infective 
trophozoite stages. The 
typically quadrinucleate 
stage (Manson-Bahr and 
Apted, 1982). Trophozoites do not transmit the disease 
because they cannot survive for any length of time 
outside the body and if ingested live, are most prob­
ably destroyed by gastric juices (Manson-Bahr and 
Apted, 19 8 2 ) . 
Entamoeba histolytica has been grouped into pathogeni .c 
and non-pathogenic zymodemes by isoenzyme electrophor­
esis based on the electrophoretic mobility of certain 
of its isoenzymes. Both the zymodemes have been iso­
lated from asymptomatic individuals, but only the 
pathogenic zymodemes cause the clinical disease 
(Jackson et ai., 1985). Pathogenic strains are charac­
terised by the presence of a relatively fast migrating 
phosphoglucomutase (PGM) isoenzyme which localises at a 
position termed beta(�) and the absence of an alpha 
(�) band, together with a faster migrating pair of 
hexokinase (HK) isoenzymes. Non-pathogenic zymodemes 
show the presence of an alpha band in 
running bands in HK (Sargeaunt et al, 
From the point of view of treatment 
PGM and slow 
1982 and 1987). 
(Gathiram and 
3. 
Jackson, 1987) as well as the interpretation of sero­
logical tests (Jackson et al, 1985, sargeaunt et al, 
1987) such differentiation is considered to be vital 
(Jackson et al, 1985; Sargeaunt et al, 1987). 
It was estimated by Walsh (1986) that 
480 million people are infested with h 




antibodies against the trophozoite indicate past or 
present invasive amoebiasis, Walsh (1986) calculated 
that annually 48 million people (approximately 10% of 
infected individuals) suffer from invasive amoebiasis. 
She (Walsh, 1986) estimated that ALA accounts for 2-
20% of all cases of invasive amoebiasis. Mortality 
from ALA has been reported to be between 2-10% and the 
annual world mortality attributable to amoebiasis has 
been estimated to be 40-110 thousand (WHO, 1985). On a 
global scale, � histolytica is the third leading 
cause of death from parasitic infections after malaria 
and schistosomiasis (Walsh, 1986). 
Microscopical identification of Entamoeba histolytica 
continues to be the 'gold standard' for the diagnosis 
of amoebiasis (Healy, 1986). The detection of ery­
throphagous trophozoites in stool specimens or tropho-
4. 
zoites in liver aspirates indicates active invasive 
amoebiasis. However, stool microscopy is difficult and 
subjective (Healy, 1986). Where morphological diag-
nosis is difficult, a demonstrable immune response may 
help confirm or refute microscopic findings (Powell et 
al, 1965/1966). 
1.2. LITERATURE REVIEW OF IMMUNODIAGNOSTIC TESTS FOR INVA­
SIVE AMOEBIASIS 
In any infectious disease the most reliable method of 
diagnosis i'"; by identifying the responsible organism 
either by microscopy or culture. Local experience with 
culture showed it to be four times more effective than 
microscopy in identifying� histolytica (Gathiram et 
al, 1984). Gathiram et al (1984) showed that direct 
microscopy of the amoebic pus revealed� histolytica 
in 21% of all ALA patients, and when culture techniques 
alone were employed� histolytica was identified in 
73% of pus specimens. Culture combined with microscopy 
increased positive identification to 81%, thereby 
making the amoebic aetiology of ALA unquestionable 
(Gathiram et al, 1984). Culturing the amoebae is 
useful in diagnosing ALA but this is difficult except 
in the research situation. The technique requires an 
5. 
experienced microscopist and technical expertise; 
furthermore, specimens must reach the laboratory within 
12 hours because the amoebae cannot survive outside the 
human host for longer periods (Gathiram et al, 1984). 
However, the body does develop a specific immune res­
ponse and detection of antibodies can be used as indi­
rect evidence of ALA (Salata and Ravdin, 1986). The 
earliest attempts at detecting circulating antibodies 
to .E..,_ histolytica were made using the complement fixa­
tion (CF) bentonite flocculation (BF) intradermal (ID) 
and amoeba immobilisation tests (Sadun, 1976). These 
tests lacked sensitivity and specificty; they were 
tedious to perform and technically difficult; the 
antigens used in these tests were obtained from L 
histolytica grown in association with other microflora 
which made standardisation of antigens difficult 
(Sadun, 1976). These problems were overcome with the 
successful cultivation of .E..,_ histolytica in an axenic 
medium (Diamond, 1968). The preparation of suitable 
antigens from such amoebae was a turning point in the 
field of diagnostic serology, because it provided anti­
genic material which was more defined and reproducible, 
thereby increasing the sensitivity and specificity of 
6. 
the serological tests. More sensitive and specific 
methods, viz. the amoebic gel diffusion test (AGDT); 
indirect haemagglutination test (IHA); counter-current 
immuno-electrophoresis (CCIE); radio-immunoassay (RIA) 
and enzyme-linked immunosorbent assay (ELISA) are dis­
cussed in more detail. 
Before discussing the various serological tests that 
are currently available in amoebiasis, the following 
comments need to be made since interpretation of 
results obtained with these different tests is depen­
dent upon understanding these concepts. 
1. In general, in invasive amoebiasis, whether it is 
amoebic dysentery (AD) or amoebic liver abscess 
(ALA), the tests are positive in the range of 95%-
100% for ALA and 60%-95% for AD. 
2. In non-endemic. areas, in both asymptomatic cyst 
passers and non-cyst passers, the tests are posi­
tive in less than 5% of individuals. 
3. In areas endemic for amoebiasis, the following 
results are obtained: 
a) Asymptomatic cyst passers: in general, sero-
positivity is in the range of 20%-50%. 
b) In non-cyst passers: seropositivity is ob­
tained in 10%-30%. 
7. 
These latter groups are important because a positive 
result obtained with these tests is not thought to 
represent a non-specific reaction. The explanation for 
this is believed to be as follows: 
i) Amoebic antibodies are known to persist for 
several years after treatment (Krupp and Powell, 
1971b and Joyce and Ravdin, 1988). 
ii) Asymptomatic cyst passers of pathogenic zymodemes
are strongly seropositive whilst asymptomatic 
cyst passers of non-pathogenic zymodemes are 
either weakly or moderately positive or seroneg­
ative (Jackson et al, 1985). 
1.2.1. Indirect Haemagglutination Test 
Use of the indirect haemagglutination test was first 
described by Kessel et al (1961). The procedure was 
subsequently modified using antigens derived from 
axenic cultures of E....e_ histolytica (Krupp, 1969 and Om 
Prakash et al, 1970). 
The IHA test has a sensitivity of 91%-100% in cases of 
ALA, and 92%-100% in acute amoebic dysentery (Kessel et 
al, 1965; Maddison et al, 1965a/b, 1968a; Milgram et 
al, 1966; 
1971a). 
Om Prakash et al, 1969 and Krupp and Powell, 
In endemic areas, resuslts vary in asympto-
8. 
matic cyst passers from 0%-45% (Maddison et al, 1968a; 
Krupp and Powell, 1971a and Gandhi et al, 1987), and 
0%-32% in hospitalised patients with diseases other 
than amoebiasis who did not pass cysts (Maddison et al, 
1968a; Krupp and Powell, 1971a and Vinayak et al, 
1975). 
The advantages of the IHA test are: 
i) It does not require specialised equipment 
(Ambroise-Thomas, 1980); 
ii) It is simple to perform (Ambroise-Thomas, 1980); 
iii) The test can be completed in less than 4 hours 
(Draper and Lillywhite, 1984); 
iv) The use of microtitre plates which facilitates 
visual reading, substantially reduces the volume 
of reagents required to perform the test (Sadun, 
1976). 
The disadvantages of the IHA test are: 
i) Its relatively poor reproducibility and lack of 
specificity (Sadun, 1976); 
ii) Variable results observed with IHA depends on
whether the erythrocytes are treated with tannic
acid, formalin, other aldehydes or chromium chlo­
ride before the amoebic antigen is adsorbed onto
the cell surface (Sadun, 1976 and Draper and
9. 
Lillywhite, 1984). Moreover, cells of one 
animal species provide more reproducible results 
with a given antigen than cells of another donor 
species (Sadun,1976); 
iii) The test reagents and fragile erythrocytes remain
stable for 2 weeks only (Kessel et al 1965;
Sadun, 1976 and Draper and Lillywhite, 1984).
1.2.2. Amoebic Gel Diffusion Test 
The amoebic gel diffusion test (AGDT) was first des­
cribed by Atchley et al (1963). The AGDT has a sensi­
tivity of 91-100% in cases of ALA and 88-97% in amoebic 
dysentery (Maddison, 1965; Maddison et al, 1965a/b, 
1968a; Powell et al 1965, 1966; Morris et al 1970b; 
Krupp and Powell 1971a; Monroe et al, 1972; Vinayak 
et al, 1975; Patterson et al, 1980; Jackson et al, 
1984 and Shetty et al, 1988). In asymptomatic cyst 
passers of h histolytica the prevalence of seropos­
itivity varies from 0% in non-endemic areas (Patterson 
et al, 1980) to 39%-50% in endemic areas (Maddison, 
1965; Maddison et al, 1965a and Krupp and Powell 
1971a). The higher seropositivity observed with asy-
mptomatic cyst passers in endemic areas may be due to 
higher prevalence of pathogenic h histolytica in these 
10. 
areas compared to non-endemic areas (Jackson et al, 
1985 and Gathiram and Jackson, 1987). In a semi-rural 
area south of Durban, the overall prevalence of patho­
genic and non-pathogenic zymodemes has been shown to 
occur in approximately 10%, pathogenic zymodemes occur 
in approximately 1% of apparently asymptomatic individ­
uals (Gathiram and Jackson, 1987). The proportions of 
seropositive responses ranged from 31% for carriers of 
non-pathogenic zymodemes to 100% in carriers of patho­
genic zymodemes (Jackson et al, 1985). In endemic 
areas a seropositivity of 10%-20% was observed in hos­
pitalised patients with no clinical evidence of amoe­
biasis and who were not cyst passers (Maddison, 1965; 
Maddison et al, 1965a/b, 1968b; Powell et al, 1965, 
1966; Krupp and Powell 1971a and Vinayak et al, 1975). 
In similar groups of patients a positivity of less than 
0,9% were observed in non-endemic areas (Monroe et al, 
1972, and Patterson et al, 1980). The higher preval-
ence of seropositivity reported in endemic 
areas in individuals without invasive amoebiasis may be 
due either to a past infection with .IL_ histolytica, as 
amoebic antibodies are known to persist for 2 years or 
longer after successful treatment (Krupp and Powell, 
1971b and Joyce and Ravdin, 1986), or to a higher 
11. 
prevalence of pathogenic h histolytica in an endemic 
environment (Jackson et al, 1985). A negative AGDT 
result is significant in that it makes a diagnosis of 
ALA unlikely. The advantages of the AGDT are: 
i) Its reproducibility and low cost;
ii) rt is interesting to note that the AGDT is useful
in detecting asymptomatic cyst passers of patho­
genic h histolytica (Jackson et al, 1985). This 
is not due to any specific characteristic of the 
AGDT, but to its ability to detect higher anti­
body concentrations; 
iii) Jackson et al (1985) using the AGDT and indirect
fluorescent antibody test (IFAT) concluded that a
strong positive serological response is highly
indicative of the presence of a pathogenic zymo­
deme.
The disadvantages of the AGDT are: 
i) It requires a certain degree of technical exper­
tise in its performance (Elsdon-Dew et al, 1971); 
ii) Interpretation of results is subjective (Elsdon­
Dew et al, 1971);
iii) The test has a clinical disadvantage in that a 
12. 
result is obtainable 24-48 hrs after receipt of a 
specimen; an unequivocal negative result is 
obtained in 48 hours (Morris et al, 1970a and 
Monroe et al, 1972). Repetition of the test for 
confirmation takes even longer (Morris et al, 
1970a and Monroe et al, 1972). 
1.2.3. Latex Agglutination and Cellulose Acetate 
Membrane Tests 
With the exception of IFAT, CCIE and_ ELISA most sero­
logical test results cannot be reported on the same day 
when blood specimens are received. This can be of 
clinical disadvantage when an urgent decision needs to 
be made (delaRey Nel et al, 1989). Under such cir-
cumstances there is a 'need for a simple quick test' to 
confirm clinical impressions (Elsdon-Dew, 1971). To 
this end the latex.agglutination (LA) (Morris et al, 
1970b) and the cellulose acetate membrane precipitin 
(CAPT) (Stamm and Phillips, 1977) tests were developed. 
Morris et al (19709a/b) using the LA test reported a 
sensitivity of 98% for ALA and 96% for amoebic dysen-
tery. The test has the advantage of being rapid with 
results being provided within 5-10 minutes. The test 
is qualitative and interpretation can be subjective. 
13. 
Furthermore, the inability to standardise the reagents 
for the LA test and the high cost of the Serameba kit 
(Ames Co., USA), made the test inaccessible to Third 
World laboratories with limited funds (Stamm et al, 
1973 and Mahajan et al, 1976a). The CAPT is similar to 
the AGDT, but it utilises cellulose acetate membrane 
instead of agarose as the support medium. The only 
advantage of the CAPT has over the AGDT is the speed 
with which the results are available, 4 hours compared 
to 24-48 hours with the AGDT (Stamm and Phillips,1977). 
The membrane is easier to handle than agar; however, 
the membrane must be stained to show arcs of precipitin 
(Stamm and Phillips, 1977). 
1.2.4. Immunoelectrophoresis 
The technique of immunoelectrophoresis (IEP) was first 
applied to amoebiasis by Maddison (1965) to demon­
strate precipitating antibodies in the sera of two ALA 
patients. A more extensive study using the IEP in 
amoebiasis was undertaken by Savanat and Chaicumpa 
(1969) to assess its value in the diagnosis of invasive 
amoebiasis. Savanat and Chaicupma (1969) reported 
seropositives of 96,8% in patients with ALA and 66,7% 
in those with amoebic dysentery from an area endemic 
14. 
for amoebiasis in Thailand. In addition, Savant and 
Chaicumpa (1969) noted that 0,6% of blood donors and 
7,4% of individuals with unrelated diseases were 
seropositive. Krupp and Powell (1971b) in 448 patients 
(with proven ALA and amoebic dysentery) and Savanat and 
Chaicumpa (1969) in 6 ALA patients used the IEP to 
differentiate between precipitin arcs present during 
active disease and those persisting after treatment. 
In their respective studies they noted that certain 
antigen-antibody arcs were lost with treatment. Their 
results suggested that the IEP test may be of some 
value in differentiating between past and recent infec-
tion. However, such studies using the IEP test were 
not pursued any further. 
The only known advantage of the IEP is that it offers 
better resolution of the precipitin bands than the 
AGDT (Savant and Chaicumpa, 1969). 
of the assay are: 
The disadvantages 
i) It requires relatively large quantities of rea­
gents (Ambroise-Thomas, 1980); 
ii) It takes a long time to complete (72 hours) 
(Ambroise-Thomas, 1980); 
15. 
iii) The assay is cumbersome to perform and requires 
expensive equipment, which has restricted its 
general use routinely. 
1.2.5. Counter-current immunoelectrophoresis 
The use of counter-current immunoelectrophoresis (CCIE) 
in amoebiasis was first described by Sepulveda et al 
(cited by Ambroise-Thomas, 1980). The sensitivity of 
CCIE was reported to be 95-100% for ALA and 47-88% for 
amoebic dysentery (Krupp, 1974; Mahajan et al, 1976a; 
Alper et al, 1976; Tosswill et al, 1980; Garcia et 
al, 1982 and Sharma et al, 1984; Samrejrongroj and 
Tharavanij, 1985). In all of these studies, the CCIE 
was reported to be 100% specific, including the study 
of Krupp (1974). However, in this particular study, 
the AGDT was also 100% specific. This makes it virtu­
ally impossible to assess the true value of the CCIE 
because it is well known that in the Durban area where 
the work was done, the specificity of the AGDT for 
active amoebiasis is only 80%-90% (Krupp and Powell, 
1971a/b). Thus the real value of the CCIE is not known. 
The ability of CCIE to detect asymptomatic cyst passers 
of .E....,_ histolytica has not been evaluated. 
16. 
The advantages of CCIE are: 
i) It is economical in respect to reagents and anti­
gen used;
ii) The assay is rapid; it can be completed in 1-2 
hours after receipt of the specimen (Mahajan et 
al, 197 5). 'l'o improve accuracy, results are read 
at 24 hours (Mahajan et al, 1975 and Alper et al, 
1976) . 
The disadvantages of the CCIE are: 
i) It requires expensive equipment and some technical
expertise;
ii) Weak precipitin lines are occasionally difficult 
to distinguish from artifacts that are often seen 
close to the antiserum well (Kohler et al, 1982). 
1.2.6. Indirect Fluorescent Antibody Test 
Jeanes (1966) and Goldman (1966) simultaneously des­
cribed the use of immunofluorescence in amoebiasis. 
The sensitivity of the indirect fluorescent antibody 
test (IFAT) for the diagnosis of ALA varies between 
96%-100% and 54%-95% for amoebic dysentery. In areas 
endemic for amoebiasis the IFAT is seropositive in 9%-
24% of asymptomatic cyst passers and in up to 12% of 
hospitalised patients (Jeanes, 1966; 1969; Ambroise-
17. 
Thomas and Truong, 1972; Ambroise-Thomas 1976 and 
Jackson et al, 1984).
One of the main advantages of the IFAT is the use of 
anti-immunoglobulins to detect different classes of 
human immunnoglobulins (Jackson et al, 1984). These 
authors (Jackson et al, 1984) reported that the IgG­
IFAT was seropositive in all 35 (100%) ALA patients and 
in 19% (3/16) of hospitalised patients with diseas2s 
other than amoebiasis. The IgM-IFAT was scropositivc in 
83% (29/35) of ALA patients and in 6% (1/16) of 
patients with other diseases (Jackson et al, 1984).
Jackson et al (1984) used the AGDT and the IFAT in a 
longitudinal study of patients with ALA. They found 
that in more than 50% of patients with invasive amoe-
biasis, specific IgM antibodies became negative soon�r 
·4
(within 3-6 months) than the IgG. Tll�se authors
(Jackson et al, 1984) proposed that when the IgM-IFAT
is negative evpn though the IgG-IFAT and ACDT may 
' . 
remain positive, active disease is absent. The presenc0 
of specific IgM (evfn in low titres) indicates current
tissue invasion by� histolytica. Similar obser-
vations with regard to IgM antibodies were reported by 
others (Ambroise-Thomas and Truong 1972 and Ambroise-
Thomas, 1976). 
Advantages of the IFAT are: 
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i) The whole parasite is used as the antigen; this 




coated slides used for the IFAT 
for more than 6 months when stored 
-20
°
C (Thomas et al, 1981 and Ambroise-Thomas 
and Truong, 1972). 
are 
at 
iii) IFAT results are available 1-2 hours after 
receipt of a specimen. 
iv) Different classes of immunoglobulins can be 
measured (Jackson et al, 1984). 
The disadvantages of the IFAT are: 
i) That interpretation of immunofluorescence is 
subjective and depends on the technical exper­
tise of the microscopist (Sadun, 1976).
ii) The test requires a fairly intricate microscope
(Ambroise-Thomas, 1976).
iii) The assay is difficult or even impossible to
automate (Ambroise-Thomas, 1976).
Time-resolved fluoroimmunoassay (TR-FIA) (Aceti et al, 
1987) is a modification of the IFAT. The assay uses a 
chelate of the lanthanide europium 
instead of fluorescien isothiocynate. 
19. 
as the label, 
The chelate red-
uces non-specific reactions and background fluorescence 
(Aceti et al, 1987). The assay was positive in 90% of 
patients with invasive amoebiasis; it was positive in 
1,6% of patients with diseases other than amoebiasis, 
and in 18% of sera obtained from other individuals. 
In the latter, no clinical data were available; pres-
umably they had no clinical evidence of active amoe-
biasis (Aceti et al, 1987). Unlike conventional IFAT, 
TR-FIA detects antibodies to soluble antigens adsorbed 
to microtitre plates. The assay is more quantitative 
and less subjective than IFAT (Aceti et al, 1987). The 
application of TR-FIA in diagnosing invasive amoebia­
sis, especially in areas endemic for amoebiasis needs 
to be evaluated . .  However, the use of an expensive 
specialised equipment, viz. a fluorimeter, may restrict 
its use in poorer laboratories. 
1.2.7. Enzyme-linked Immunosorbent Assay 
The enzyme-linked immunosorbent assay (ELISA) reported 
by Engvall and Perlmann (1971) was first applied to 
amoebiasis by Bos et al (1976). The assay is sensitive 
(97-100%) and specific (96-97%) for the diagnosis of 
20. 
ALA (Yang and Kennedy, 1979; Agarwal et al, 1981; Lin 
et al, 1981; Tandon, 1981; Mahapatra and Sen, 1983; 
Baveja et al, 1984 and Gandhi et al, 1987). Variable 
results have been observed for amoebic dysentery (63-
100%), but fewer papers have been published on this 
form of amoebiasis (Agarwal et al, 1981; Tandon, 1981; 
Mahapatra and Sen, 1983 and Kumar et al, 1985). The 
ELISA is positive in 2-10% of subjects from endemic 
areas who have no clinical evidence of amoebiasis. 
(Yang and Kennedy, 1979; Bos et al, 1980; Agarwal et 
al, 1981 and Baveja et al, 1984). 
The seropositivity of the test for the detection of 
asymptomatic cyst passers of .E...,_ histolytica varies 
between 0% to 50% (Lin et al, 1981 and Gandhi et al, 
1986, 1987). However, the ability of the ELISA to 
detect such individuals has not been comprehensively 
evaluated. 
The ability of the ELISA to differentiate between past 
and current infection by detecting specific IgM-anti-IL.. 
histolytica antibodies has not been evaluated. 
Researchers using the ELISA have measured either speci­
fic IgG-anti-IL.. histolytica antibodies (Yang and 
Kennedy, 1979; Agarwal et al, 1981; Mahapatra and 
21. 
Sen, 1973; Baveja et al, 1984 and Gandhi et al, 1987) 
or total anti-1.h histolygica immunoglobulins (Bos et al 




advantages of the ELISA are: 
It is a simple, rapid and sensitive test 
(O'Sullivan et al, 1979) free from the hazards of 
radioisotopes (Voller et al, 1977a). 
ii) The reagents are stable and minute quantities are
used (Voller et al, 1977b and Draper and Lilly­
white, 1984).
iii) The assay has an objective numerical readout and 
it can be fully automated (Mathews et al, 1984). 
iv) The entire assay can be performed in 2 1/2 hours,
the antigen sensitised plates have been shown to
remain stable on storage (Yang and Kennedy, 1979
and Lin et al, 1981).
Disadvantages of the ELISA: 
i) Single evaluations in solid state microtitre plates
are not practical. Test sera must be assayed in
batches. However, the availability of strips and
single wells is a major improvement on the ELISA.
ii) Serial dilution of test sera to determine the diag­
nostic endpoint titre can become labour intensive
22. 
and tedious. However, the use of single test dil-
ution can obviate this disadvantage. 
iii) A disadvantage of the ELISA is that it utilises an
expensive plate reader. This may limit its use in
poorer Third World Countries in the Tropics, where
it is most needed.
Whilst serological tests are of great value, they do 
not adequately differentiate between present and a 
previous amoebic infection. In this dissertation the 
IFAT is re-evaluated; an indirect ELISA is evaluated 
using crude soluble and plasma membrane antigens of .E...,_ 
histolytica, for detecting specific IgG and IgM-anti­
bodies, to assess its value in differentiating past 
from current amoebic infection. 
Patients with amoebic dysentery respond well to treat­
ment, and are usually discharged from a tertiary hospi­
tal like King Edward VIII, before the results of stool 
microscopy, serology 
(Solomon et al, 1984). 
or biopsy reach 





with amoebic liver abscess (ALA) are usually admitted 
to hospital and are treated under supervision. There­
fore, in this dissertation more emphasis has been 
placed in evaluating serological tests to aid the diag­
nosis of ALA. 
23. 
CHAPTER� 
EVALUATION OF THE INDIRECT FLUORESCENT ANTIBODY TEST 
(IFAT) IN THE SERODIAGNOSIS OF AMOEBIC LIVER ABSCESS 
(ALA) 
systemic humoral immune response in patients with invasive 
amoebiasis is characterised by specific circulating anti-
bodies predominantly of the IgG class (Trissl, 1982). IgG-
anti-.E....,_ histolyticn antibodies persist over a long period or 
decline slowly after treatment (Osisanya and Warhurst, 1980; 
Knobloch and Mannweiler, 1983; Jackson et al, 1984 and Pinon 
et al, 1987). IgG is the major class of antibody detected by 
most serological tests for invasive amoebiasis (Maddison et 
al, 1968b; Savanat and Chaicumpa, 1969 and Dasgupta, 1974). 
A drawback of most serodiagnostic tests is that persisting 
IgG antibodies can be detected in patients long after diag­
nosis, therapy and presumed cure have taken place (Healy, 
1986). Therefore, most of the conventional serological tests 
for invasive amoebiasis are unable to differentiate between 
past and current amoebic infection (Healy, 1986). 
The results of earlier researchers (Bray and Harris, 1977; 
Harris et al, 1978 and Osisanya and Warhurst, 1980) indicate 
that monitoring specific IgM-anti-.E....,_ histolytica antibodies 
may constitute an important feature of current diagnosis 
24. 
since they persist for a shorter period. The presence of IgM 
antibodies in invasive amoebiasis was confirmed in the early 
stages of ALA using class specific antisera in the IFAT 
(Jackson et al, 1984). The regression of IgM antibodies in 
less than 3-6 months in more than 50% of patients with inva­
sive amoebiasis suggests that detecting specific IgM-anti-E....e.. 
histolytica antibodies may be more valuable in diagnosing 
current amoebic infection (Jackson et al, 1984). 
This study re-evaluates the indirect fluorescent antibody 
test (IFAT) for the diagnosis of amoebic liver abscess (ALA). 
2.1. MATERIALS AND METHODS 
2.1.1. Antigen 
A 48 hour axenic culture of h histolytica strain HK9 
was supplied by the RIDTE in screw-capped glass test 
tubes. The glass tubes were cooled in ice water for 10 
minutes to dislodge the amoebae adherent to the glass 
surfaces. The amoebic suspension was transferred to a 
sterile, cold 10ml glass conical centrifuge tube and 
pelleted by centrifugation (Beckman Model J6B centri-
fuge; JS4.2 rotor, 800rpm (160xg) 
<;> • 
at 4 C, 10 mins). 
The amoebae were washed with cold Ringers solution by 
centrifugation at 800 rpm (160xg) at 4
°
C. The washing
procedure was repeated twice. The sediment from the 
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final wash was suspended in 1ml of cold Ringers 
solution. Ten microlitres (lOul) of the suspension 
was pipetted into each well of a 12-well Teflon-coated 
multitest slide (Flow Laboratories Inc., McLean, Va). 
The slides were air-dried in an oven at 60
°
C for 1 
hour. Slides were stored at -20 ° c and allowed to 
reach room temperature before being used for IFAT. 
2.1.2. Serology 
2.1.2.1. Indirect Fluorescent Antibody Test 
The IFAT was initially performed 
method described by Jackson et al 
according to the 
(1984). However, 
non-specific background fluorescence was observed in 
all samples tested. Thereafter, attempts were made to 
reduce the non-specific background fluorescence by 
including 
agent, at 
bovine serum albumin (BSA), a blocking 
various concentrations (1%-6%),in the serum 
diluent. In addition, the conjugates were centrifuged 
to remove any debris that may have enhanced the non-
specific 
ible. 
background fluorescence. No pellet was vis­
Rhodamine, which is dessicated normal bovine 
serum conjugated with Lissamine Rhodamine, was used as 
a counterstain to prevent non-specific binding of the 
conjugated fluorescein. These attempts to reduce non-
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specific background fluorescence were unsuccessful. 
The IFAT of Jackson et al (1984) was modified. In the 
modified assay, Tris saline (TS) buffer, pH 8,0 re­
placed phosphate buffered saline (PBS)-Tween 20 + 2% 
normal rabbit serum as the serum diluent. TS-Tween 20 
(TST) replaced PBS-Tween 20 (PBST) as the washing 
buffer. Specific FITC conjugates obtained from Sigma 
Chemicals (St. Louis, MO, U.S.A.) replaced those 
obtained from Miles-Yeda (Rehovot, Israel). TST 
replaced PBS as the conjugate diluent. All incubations 
in the modified IFAT were performed at 4
°
C as opposed 
to room temperature. 
2.1.2.2. Performance of the Modified 
Fluorescent Antibody Test. 
Indirect 
The test sera were diluted in Tris saline (TS) buffer, 
pH 8.0. Ten microlitres (lOul) of serial two-fold 
dilutions of the test sera beginning at 1/25 were 
applied to the antigen-coated slide in duplicate. 
Slides were incubated at 4
°
C for 30 minutes in a humid 
container. The slides were stacked in a staining rack 
and placed in a staining jar. The slides were washed 
by continuous stirring in TST for 5 minutes. This 
washing procedure was repeated three times with fresh 
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TST at each wash. The slides were allowed to air-dry 
at room temperature. Goat-antihuman IgG (gamma ('i) 
chain specific) FITC conjugate or goat-antihuman IgM 
(mu-(u) chain specific) FITC conjugate (Sigma Chem­
icals, St. Louis, MO, U.S.A.) was diluted 1/20 in TST. 
Ten microlitres (l0ul) of the conjugate was applied to 
each well. The slides were incubated at 4
°
C for 30 
minutes. Thereafter, the slides were washed as des­
cribed above in three changes of TST Qf 5 minutes each. 
Glass cover slips were mounted on the slides with 10% 
glycerol in 0,0lM phosphate buffered saline (PBS), pH 
7,1. The slides were read in an incident light fluores­
cence microscope ('Axioskop' H, DIC, Zeiss, West 
Germany). The reciprocal of the highest dilution of 
the serum that fluoresced was defined as its end point 
titre. Included in each slide in the IFAT was a neg­
ative serum from a normal healthy subject, a positive 
serum from a clinically diagnosed ALA patient, a well 
with diluent (TS) substituted for serum and a well con­
taining only the conjugated antibody were also in­
cluded. The fluorescence was read in duplicate rela­
tive to a negative control serum. 
28. 
2.1.3. Study Population 
The initial part of the study included 58 patients; 
the sera from 33 ALA patients were obtained from Dr. 
E.M. Irusen. All patients were diagnosed by ultrasonic 
detection of a liver defect; in addition all patients 
had a positive AGDT (20 hrs). Sterile amoebic pus was 
aspirated from 23 patients. Stool microscopy was 
positive for h histolytica in 17 patients and cultured 
from 18. In these 18 patients the zymodemes of the 
isolates were determined by isoenzyme electrophoresis 
(Jackson et al, 1985). They were all pathogenic. The 
25 normal healthy subjects served as controls. They 
had no clinical evidence of amoebiasis. Their AGDT 
were negative and their stools negative for h histo­
lytica. All sera were stored in aliquots of 200ul at -
20
°
c. No serum specimen was thawed more than once. 




subjects studied previously (Sathar 
These sera were randomly selected. 




healthy African subjects and 8 of 103 hospitalised 
patients with various diseases other than amoebiasis. 
These 28 sera were coded by Mr. M. Naicker and Dr. R. 
29. 
Nadar of the Gastrointestinal Unit, Department of 
Medicine. The IFAT on these sera (28) was performed by 
the author (MAS) and Mrs. C.B. Anderson of the RIDTE, 
without foreknowledge of the patients diagnosis. 
2.2. RESULTS 
The distribution of the IFAT end point titres for both 
IgG and IgM are shown in Figs. 2.1 and 2.2 (page 31), 
respectively. IgG-anti-fu histolytica antibody titres 
of the 33 ALA patients ranged from 1/1600 to 1/12800 
(Fig. 2.1). They did not overlap those of the negative 
control group. The IgG titres of the normal healthy 
controls ranged from Oto 1/400 (Fig. 2.1). Only 1 of 
25 normal healthy control sera had an endpoint titre of 
1/400 (Fig. 2.1). Anti-fu histolytica IgM titres of 
the 33 ALA patients ranged from 1/25 to 1/400 (Fig. 
2.2). The IgM titres of the healthy control sera 
ranged from Oto 1/100 (Fig. 2.2). Of the 33 ALA sera 
29 had IgM titres greater than(>) 1/25 whereas only 5 
of 25 control sera had titres greater than (>) 1/25 
(Fig. 2.2). Using a titre of >1/500 in the IgG-IFAT to 
indicate seropositivity similar to that used by Jackson 
et al (1985), all 33 (100%) ALA patients were seropos­
itive. There were no false positives in the control 
group (Fig. 2.1) With the IgM-IFAT, 88% (29/33) of 
30. 
ALA patients were positive when a titre of greater than 
(>) 1/25 was considered to be seropositive; there was 
a false positive rate of 20% (Fig. 2.2). The end 
point titres of 1/500 and 1/25 for IgG-IFAT and IgM­
IFAT were used to differentiate seropositive from sero­
negative subjects. 
Results of the IgG-IFAT and IgM-IFAT among the various 
study groups are shown in Table 2.1. 
positive in all 10 cases of 
The IgG-IFAT WAS 
ALA (100%). No 
seropositives were recorded in either the 10 healthy 
controls or the 8 patients who had no clinical evidence 
of amoebiasis (Table 2.1). There was total agreement 
between the two independent observers in the interpre­
tation of IgG immunofluorescence for the 28 patients. 
TABLE 2.1: RESULTS. OF IgG-IFAT AND IgM-IFAT IN THE 
VARIOUS STUDY GROUPS 
-------------------------------------------------------
STUDY GROUPS 
Amoebic liver abscess 
Normal healthy controls 
Hospitalised patients 



















The IgM-IFAT was positive in 5 of 10 (50%) ALA patients 
(Table 2.1). In 8 patients without any clinical evid­
ence of amoebiasis 3 were positive by the IgM-IFAT 
test. The 10 healthy controls were negative by the IgM-
IFAT (Table 2.1). There was 89% (25/28) agreement 
between the two independent observers in the interpre­
tation of IgM immunofluorescence. 
2.3. DISCUSSION 
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The sensitivity (100%) of the modified IgG-IFAT perfor­
med either with or without prior knowledge of the 
patients disease condition is similar (96%-100%) to 
that reported by others for the diagnosis of ALA 
(Jeanes, 1966, 1969; Ambroise-Thomas and Truong, 1972; 
Ambroise-Thomas, 1976 and Jackson et al, 1984). How­
ever, the specificity (100%) of the modified IgG-IFAT 
was higher (87.5%) than that reported by Jackson et al 
(1984). The positivity of 12,5% observed by Jackson et 
al (1984) in hospitalised patients with diseases other 
than amoebiasis may be due to a past infection with� 
histolytica as was observed with the AGDT (Powell et 
al, 1965). In this experiment, hospitalised patients 
with diseases other than amoebiasis were randomly sel­
ected from a group.of patients whose AGDTs were nega­
tive. This may account for the higher specificity 
(100%) recorded with the IgG-IFAT. It is well documen­
ted in this endemic area for amoebiasis, that in 15-20% 
of such individuals, the AGDT is seropositive (Powell 
et al, 1965 and Jackson et al, 1985). There was 100% 
agreement between the two independent observers in the 
interpretation of the intensity of the fluorescence 
recorded as a numerical value from +l to +4 for IgG-IFAT. 
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The specificity (83%) of the IgM-IFAT when performed on 
sera which were coded was not markedly different 
(80%) to when the test was performed on sera where the 
diagnosis of the patient's condition was known ; how­
ever, the specificity was lower than that of 93,75% 
reported by Jackson et al (1984). The sensitivity 
(88%) of the modified IgM-IFAT was not markedly diff­
erent to that (83%) reported by Jackson et al (1984), 
when the assay was performed on known serum samples. 
However, when the IgM-IFAT was performed coded, its 
sensitivity was reduced to 50%. The interpretation of 
IgM immunofluorescence was subjective. The results of 
the more experienced observer were recorded. The 
overall agreement between the two independent obser­
vers in the interpretation of the intensity of the 
fluorescence recorded as +1 to +4 for the IgM-IFAT 
was 89%. 
It is difficult to make a comparison between the modi­
fied IFAT and the IFAT of Jackson et al (1984), espe­
cially with regard to their specificity. The IFAT 
test was different to that of Jackson et al (1984); in 
addition, Jackson et al (1984) determined the specif­
icity of the IFAT using hospitalised patients with 
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diseases other than amoebiasis. In the present study 
specificity was determined using normal healthy 
subjects as controls. In the former group of patients, 
15-20% are known to be seropositive, due to persisting 
antibodies (Krupp and Powell, 1971b). This probably 
accounts for the discrepancies observed between the two 
methods with regard to their specificity. 
The results not only underlines the subjectivity of 
the IFAT, especially the interpretation of IgM immuno-
fluorescence, but stresses the importance of performing 
the IFAT without prior knowledge of the patient's 
disease. In addition, the interpretation of immuno-
fluorescence must be based on the observations of two 
or more independent, skilled microscopists. Based on 
these observations, a simple quantitative and a less 
subjective test needs to be evaluated to detect spec­
ific IgM-anti-fu... histolytica antibodies to differen­





ENZYME-LINKED IMMUNOSORBENT ASSAY 
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class of antibodies detected by most serological 
in invasive amoebiasis is IgG (Savanat and 
1969 and Dasgupta, 1974). In an endemic area, 
detecting specific IgM antibodies might be more useful in 
determining whether or not there is active/current amoebic 
infection, since IgM antibodies persist for a shorter time. 
Jackson et al (1984), using the IFAT, showed that monitoring 
specific IgM-anti-E....... histolytica antibodies was of some value 
in differentiating past from current infection. However, the 
application of the IFAT in the routine diagnosis of amoebia­
sis has been limited by the fact that its performance 
requires expertise. Furthermore, the interpretation of 
immunofluorescence is subjective and thus the results are 
not reproducible. There is a need for a more reproducible 
test. The ELISA obviates the disadvantages of the IFAT and 
fulfils the criteria of reproducibility, ease of performance 
and non-subjectivity (O'Sullivan et al, 
al, 1976). 
1979 and Voller et 
The measurement of specific IgM antibodies with the ELISA has 
been shown to be valuable in differentiating current from 
past infections in other parasitic infections, viz. giardia-
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sis (Goka et al, 1986) and toxoplasmosis (Naot and Remington, 
1980). However, the ability of the assay to detect specific 
IgM-anti-E...,_ histolytica antibodies in an endemic environment 
has not been evaluated. Comparative studies of serological 
tests which have used the ELISA to detect either specific 
IgG antibodies or total immunoglobulins to 
indicate that the assay is simple to perform. 
E...,_ histolytica 
The ELISA has 
been shown to be as sensitive as the other serodiagnostic 
tests employed in the diagnosis of ALA, e.g. the IFAT, IHA,
AGDT and CCIE (Yang and Kennedy, 1979; Agarwal et al, 1981; 
Bos et al, 1980; Mohapatra and Sen, 1983; Samrejrongroj and 
Tharavanij, 1985 and Gandhi et al, 1987). 
Quantitative measurements of antibody concentrations are 
generally reported in terms of titres based on doubling 
dilutions of serum smaples. Titration to the end point when 
large numbers of sera have to be tested can become laborious 
and time consuming (Voller et al, 1977b and 1978). It would 
be much easier to determine a diagnostic optical density (OD) 
cut-off point which will differentiate normal healthy indivi­
duals from ALA patients using a single dilution of the test 
serum. The indirect method of the enzyme-linked immunosor­
bent assay (ELISA) (Voller et al, 1976, 1977b and 1978) with 
modification (Baigh et al, 1986) was applied to detect IgG 
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and IgM antibodies to 1L._ histolytica. 
Rheumatoid factor (RF) and antinuclear antibodies (ANF) in 
the presence of specific IgG antibodies can produce false­
positive results in the various assays developed for specific 
IgM (Naoat and Remington, 1980; Kohler et al, 1982). For 
this reason and because of the value of detecting IgM-anti-lL._ 
histolytica antibodies all the sera were tested for RF and 
ANF. The AGDT was used as the reference test. 
3.1. MATERIALS AND METHODS 
3.1.1. Chemicals 
All chemicals were analytical grade unless specified 
otherwise.- Tris (hydroxymethyl) aminomethane, polyoxy­
ethylene sorbitan-monolaurate (Tween 20), peroxidase 
conjugated immunoglobulin G (IgG)(gamma-chain specific) 
goat anti-human (IgG) and peroxidase conjugated IgM 
(mu-chain specific) goat anti-human (IgM) were obtained 
from Sigma Chemicals Co., St. Louis, MO, USA. 
Sodium chloride (NaCl), sodium azide (NaN3), sodium 
carbonate (Na�co�, sodium hydrogen carbonate (NaHCO�)
and hydrochloric acid (HCl) were obtained from BDH 
Chemicals Ltd., Poole, England. 
prepared in glass distilled water. 
All chemicals were 
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3.1.2. Antigen 
Soluble .E....._ histolytica antigen was obtained from the 
Research Institute for Diseases in a Tropical Environ­
ment (RIDTE) of the South African Medical Research 
Council (SAMRC), Congella, Durban. The antigen was 
prepared from a mixed culture of .E....,_ histolytica, 
strains HK-9 and NIH-200 grown axenically according to 
the technique described by Diamond (1968). The antigen 
was prepared using the method described by Jackson et 
al (1983). It had a protein concentration of 9,7mg/ml. 
3.1.3. Antigen Carrier 
Griener flat-bottom polystyrene microtitre (PS) plates 
(Dynatech, Ml29B, T & C Scientific Supplies, Durban), 
were purchas�d from stocks at the Natal Blood Trans­
fusion Services (NBTS). 
3.1 4. Enzyme Substrate 
Chromogenic substrate (18,4mM Na�B+o1 19H�0 30,SmM
succinic acid (0,36g), 3,77mM O-phenylenediamine (40mg) 
40mM urea, hydrogen peroxide (40mg), and distilled 
water to 100ml) (Conradie et al, 1980) was obtained 
from the Natal Blood Transfusion Services (NBTS) and 
the Institute of Immunology, Durban, South Africa. 
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3.1.5. Optical Density 
Optical densities (OD) were read in a Titertek Multi­
skan micro-ELISA plate reader (Flow Laboratories Inc., 
McLean, Va) at 492nm. 
3.1.6. Study Population 
Optimal conditions for the IgG- and IgM-ELISAs were 
determined by titrating a positive (ALA) and a negative 
(normal health) reference sera. The ALA patient had 
been diagnosed on clinical features, the presence of an 
amoebic liver lesion on ultrasound examination, the 
aspiration of sterile pus and a positive amoebic gel 
diffusion test (AGDT). The control serum was obtained 
from a healthy subject who had no clinical evidence of 
amoebiasis and whose AGDT and stool microscopy were 
negative. 
Sera from 93 subjects were assayed for the presence of 
anti-E...... histolytica antibodies using the AGDT and 
ELISA. The study population included: 
i) 30 African patients who had clinically diagnosed
ALA. The diagnosis was based on ultrason­
ography, response to metronidazole, a strongly 
positive AGDT (20 hrs) and bacteriologically 
sterile 
patients. 
pus which was aspirated 
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from 13 
ii) 23 Healthy African subjects who had no clinical
iii) 
iv) 
evidence of amoebiasis and in whom the AGDT and
stool microscopy was negative.
30 hospitalised patientss who had diseases other
than amoebiasis served as controls; they
included patients with tuberculosis (10) and
typhoid ( 2 0) . The AGDT was negative in all of
them.
Also included in the control group were 10 
subjects who had one of a range of unrelated 
parasites isolated from their stool, viz. 
Trichuris sp (2), Taenia sp (2), Ascaris sp (3), 
hookworm sp (1), Schistosoma haematobium (1) and 
Balantidium .coli (1). None of the control 
subjects had any evidence of amoebiasis. The 
AGDT was negative in all of them, except for the 
subject from whom a hookworm sp. was isolated. 
The OD values of each study group was expressed as its 
mean +/- standard deviation (mean +/- SD). The OD cut­
off points were determined by using the mean +/- SD of 
the normal healthy controls. 
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3.1.7. Serology 
3.1.7.1. Amoebic gel diffusion test 
The AGDT was examined for the development of precipitin 
bands over a period of 48 hours. Positivity of the 
AGDT expressed as 20 hours or 40 hours indicate when 
precipitin bands were observed. A 20 hour positive 
AGDT is regarded as a strong positive reaction and a 40 
hour positive AGDT as a weak positive reaction. 
3.1.7.2. Enzyme-linked Immunosorbent Assay 
The assay was performed as follows: 
1. The amoebic antigen was diluted in 0,05M Na�co3-
NaHco3 buffer, pH 9,6. One hundred microlitres
(l00ul) of this antigen solution was dispensed into
each of the 96 wells of the microtitre plate.
2. Plates were incubated in a humid container at room
temperature for 2 hours.
3. Plates were washed with 300ml of 0,05M Tris-saline
(TS) containing 0,05% Tween 20 (TST), followed by
200ml of distilled water in an ELISA shower
(Conradie et al, 1981).
4. The excess washing solution was emptied by
'flicking' out the contents of the microtitre
plate. The plates were dried by padding onto
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absorbent material (Softex). 
5. Plates were used within 24 hours. They were either 
used immediately or stored at 4
°
C overnight. 
6. Fifty microlitres (50ul) of the test serum was 
added to two wells. Sera were tested in dupli-
cate. Tris saline (TS) was used as the diluent for 
the sera. Both bovine serum albumin (BSA) and 
Tween 20 were used as blocking agents. 
0 
7. Plates were incubated in a humid container at 45 C
for 1 hour.
8. Plates were washed in the ELISA shower with 500ml
of TST and dried as in step 4 by 'flicking' out the
excess washing fluid and padding the plate dry onto
absorbent material (Softex).
9. Fifty microlitres (50ul) of either IgG or IgM 
conjugate diluted in TST at the manufacturer's 
recommended dilution of 1/1000, was added to each 
well.




for 1 hour in a 
12. Fifty microlitres (50ul) of chromogenic substrate 
was added to each well and the plate incubated in 
the dark at room temperature. 
13. The enzymatic reaction was stopped by adding l00ul 
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of 1,5N HCl to each well. 
14. The intensity of the colour reaction was measured 
at 492nm using a Titertek Multiskan micro-ELISA 
plate reader.
3.1.7.3. Autoantibodies 
Sera of ALA patients and normal healthy controls were 
tested for antinuclear antibodies (ANF) and rheumatoid 
factor (RF). The test for ANF was performed by the 
Natal Institute of Immunology, Department of Medicine. 
The sera were tested for RF using a 2-minute indirect 
haemagglutination (IHA) slide test (Wamplle Laborator­
ies, N.J., U.S.A.). 
3.2. RESULTS 
Optimal antigen concentration occurred between 
6,25ug/ml and 12,5ug/ml of protein for IgG- (Fig. 3.1, 
page 47) and at 6,25ug/ml for IgM-ELISA (Fig 3.2, page 
47). To conserve antigen, it was decided to coat micro­
titre plates with 6,25ug/ml of amoebic protein. 
Plates coated with amoebic antigen and stored at 4
°
C 
overnight in a sealed plastic bag containing silica gel 
were stable (Figs. 3.3 and 3.4, page 47, respectively). 
In both the IgG- and IgM-ELISA (Fig. 3.5 and 3.6, page 




C after 1 hour of incubation which gave a good 
differentiation between the ALA patient and the normal 
healthy control. An added advantage of the ELISA is 
that simultaneous dual screening of IgG and IgM anti­
bodies under identical experimental conditions saves 
considerable operator time. Therefore, both sera and 
conjugated antisera were incubated at 45
°
C for 1 hour 
in all further experiments. 
The absorbence product was linear with time for the 
first 10 minutes for both IgG and IgM (Figs. 3.7 and 
3.8, page 48, respectively). The reactivity of the ALA 
serum in the IgG-ELISA (Fig. 3.7) goes beyond the scope 
of the spectrophotometer. In order to minimize NSB of 
the conjugate and to reduce the signal to noise ratio, 
5 minutes substrate reaction time was chosen, which 
gave a good differentiation between positive and nega­
tive sera for both IgG (Fig. 3.7) and IgM (Fig 3.8). 
The reaction was stopped with 1,5N HCl in both the IgG 
and IgM-ELISAs. The substrate reaction product was 
stable for 1 hour with no marked colour change (Fig. 
3.9, page 50). 
A clear distinction between the healthy control and the 
46. 
ALA patient was observed in the IgM-ELISA when BSA was 
excluded from the serum diluent (Fig. 3.10, page 50). 




Serum titration curves for IgG- and IgM-anti-1L. histo­
lytica antibodies are illustrated in Figs. 3.11 and 
3.12 (page 50 respectively). The end point IgG-anti­
.IL. histolytica antibody titre was approximately 
1/819200 for the ALA patient and approximately 1/3200 
for healthy control (Fig. 3.11). In the IgG-ELISA (Fig. 
3.11), higher 'background noise' occurred at serum 
dilutions of 1/100 to 1/800. A single serum dilution 
of 1/6400 gave the biggest differentiation between the 
positive and negative control sera with minimum 
'background noise'. 
The end-point IgM-anti-£,.. histolytica antibody titre 
was approximately 1/3200 for ALA and 1/400 for the 
healthy control (Fig. 3.12). In the IgM-ELISA minimum 
'background noise' was observed at serum dilutions of 
1/400 to 1/800 (Fig. 3.12). At higher dilutions of 
1/1600-1/3200 the erratic OD readings are difficult to 
evaluate. A good distinction between the positive and 




To minimise 'background noise' and to obtain a good 
differentiation between seropositive and seronegative 
sera, a single test dilution of 1/6400 and 1/400 were 
chosen for the IgG- and IgM-ELISAs, respectively. 
These dilutions were used to determine the diagnostic 
OD cut-off points for the IgG- and IgM-ELISAs. The mean 
absorbance values obtained in the IgG- and IgM-ELISA 
assays for the various study groups are presented in 
Tables 3.1 and 3.2, page 53, respectively. The 'posi­
tive/negative cut-off' line which distinguished sero­
positive from seronegative sera and which gave maximum 
positivity amongst the various groups was determined by 
using the mean OD value of healthy controls plus 
three standard deviations (SD) of the mean for the IgG­
ELISA (Table 3.1) and mean plus two standard deviations 
of the mean for the .IgM-ELISA (Table 3.2). 
The IgG-ELISA at a cut-off point of mean OD + 3SD study 
(0,153) gives maximum positivity amongst the various 
groups (Table 3.1). Use of a higher cut-off point, 
e.g. 0,250 would seem more logical as it would exclude 
most of the false positives while still retaining the 
sensitivity of the test. Using an OD of 0,250, the 
IgG-ELISA was positive in 99% of ALA patients, and only 
52. 
one control patient in whom a hookworm was isolated was 
seropositive (Table 3.1). 
53. 
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In the IgM-ELISA, mean + 2SD (0,350) of normal healthy 
controls was taken as the cut-off point to distinguish 
seropositive from seronegative subjects (Table 3.2). 
Using an OD of 0,350, 63% of patients with ALA were 
positive and only 3 control patients who had typhoid 
were positive. At a lower OD cut-off (0,268), the 
sensitivity is good (83%) but specificity of the IgM­
ELISA is reduced. Therefore, 0,350 was chosen as the 
OD cut-off point, increasing the specificity of the 
assay at the expense of sensitivity (Table 3.2). None 
of the sera of ALA patients or healthy controls was 
positive for RF or ANF. 
The reproducibility of the assay was examined over a 
period of approximately 3 weeks using the same batch of 
reagents. Sera of an ALA patient and a normal healthy 
control were tested at single dilutions of 1/6400 for 
IgG- and 1/400 for IgM- E...,_ histolytica antibodies. It 
should be noted that during this period the specimens 
were stored in aliquots of 200ul at -20
°
c. No specimen 
was thawed more than once for each determination. The 
results are shown in Table 3.3, page 55. 
Table 3.3 REPRODUCIBILITY OF IgG and IgM-ELISA 
(RESULTS OVER A PERIOD OF 3 WEEKS) 
55. 
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1 1,480 0,140 0,837 0.128 
6 1,482 0,133 0,827 0,113 
8 1,311 0,165 0,840 0,104 
14 1,382 0,130 0,766 0,108 
21 1,313 0,145 0,692 0,110 
1,393 0,142 0,792 0,112 
SD 0,08 0,012 0,06 0,009 
CV ( % ) 6 9 8 8 
-------------------------------------------------------
The co-efficient of variation (CV%) of duplicate testing 
of the positive and negative control sera ranged from 
1% to 5%. In most instances they were less than 5� 0 • 
The CV(%) between assays ranged from 6% to 9% (Table 
3 . 3) . 
3.3. DISCUSSION 
56. 
With ELISA the solid phase is a critical element of 
the test system since the antigen must be bound to the 
carrier for the assay to be performed (Shekarchi et al, 
1984). Insufficient binding of the antigen decreases 
the sensitivity of the test and frequently increases 
the 'background noise'. Uneven binding decreases the 
reproducibility of the test (Sorensen and Bordbeck, 
1986). The polystyrene (PS) plate (M129B) gives a good 
discrimination between the two reference sera. The 
binding capacity of the carrier is a function of both 
its chemical and physical nature and is thus subject to 
many changes during manufacture and storage (Shekarchi 
et al, 
plates 
1984). Variations in binding 
have been found to occur between 
to microtitre 
plates made 
from the same plastic by different manufacturers and 
even between lots or batches produced by a single 
manufacturer (Shekarchi et al, 1984). It is important 
that the solid phase takes up adequate amounts of the 
antigen in a consistent reproducible manner (Sherkarchi 
et 21, 1984). Conradie et al (1981 and 1983) after 
extensive trials, obtained a co-efficent of variation 
(CV) of less than 10% with the Dynatech M129B PS micro-
57. 
titre plates. Using these plates (Dynatech Ml29B) 
similar results were obtained in the present study, 
thus confirming the observations made by Conradie et 
al (1981 and 1983). Therefore, Dynatech Ml29B PS 
plates were obtained from Dr. Conradie's large stocks 
at NBTS. 
For most proteins sensitisation of microtitre plates is 
achieved with protein concentrations of 1-lOug/ml in 
carbonate-bicarbonate buffer, pH 9,6 (Voller et al, 
1977b and 1978). Adsorption occurs rapidly, being 
completed within 1-2 hours at 20
°
c-2s·c (Voller et al, 
1977b and 1978). For convenience overnight coating at 
4
°
C is often satisfactory (Voller et al, 1977b and 
1978). Good results were obtained with plates coated 
with 6,25ug/ml of amoebic protein, incubated at room 
temperature for 2 hours. Antigen-coated plates stored 
overnight at 4
°
C were stable, however, the stability of 
the antigen-coated plates over a longer period of time 
was not determined. 
Increasing the temperature of incubation of the serum 
and conjugated antiserum speeds up the reaction time 
and decreases the binding time (Gilman and Docherty, 




vantageous since specific activity is decreased, pre­
sumably due to a combination of temperature denatur­
ation effects, disassociation of conjugated antiserum 
as well as release of the antigen from the microtitre 
plate, due possibly as a result of structural changes 
in the plastic (Gilman and Docherty, 1977). 
The chromogenic substrate is light sensitive; there­
fore, incubation was performed in the dark (Voller et 
al, 1977b and 1978). The substrate reaction product was 
stable for 1 hour. The latter is important since 
inherent colour changes could occur when considerable 
time is required in the testing of large numbers of 
sera (Bullock and Walls, 1977 and Bidwell et al, 
1977). 
In the ELISA thera is always a tendency for protein­
aceous material present in the test serum to attach in 
a non-specific manner to the solid phase (Kohler et al, 
1982). Such non-specific binding may be eliminated or 
reduced to an acceptable level by the addition of a 
'blocking' agent to the serum diluent (Vogt et al, 
1987). This is a collective term for various addit-
ives, e.g. bovine serum albumin (BSA) (Vogt et al, 
1987) or non-ionic detergents, e.g. Tween 20 (Kenny and 
59. 
Dunsmoor, 1987) that have no active part in the immuno­
chemical reactions of the assay. The reliability of 
Tween 20 as an effective blocking agent is uncertain 
(Gardas and Lewartowska, 1988) as different brands and 
batches of microtitre plates differ in their ability to 
retain non-ionic detergents (Kenny and Dunsmoor, 1987). 
Cardas and Lewarkokska (1988) have shown that effective 
binding of proteins to microtitre plates can be enhan­
ced by using detergents with a high critical micelle 
concentration (CMC). To reduce non-specific binding 
(NSB) both BSA and Tween 20 were included in the serum 
diluent but 
IgG-ELISA. 
these did not significantly 





eliminating the blocking step saves time and reduces 
costs while still reducing 'background noise' to a 
minimum, without sacrificing sensitivity and specif­
icity. When BSA was excluded from the serum diluent, 
especially in the IgM-ELISA, it resulted in a clear 
separation between positive and negative sera. 
Recently Mahomed and Esen (1989) showed that a blocking 
agent and a blocking step are not needed in the ELISA. 
To optimize the efficiency and economy of the ELISA, 
the detection of the test material (IgG/IgM-anti-.E....._ 
60. 
histolytica antibodies) in the test sample (serum) can 
usually be made on a single dilution of that test 
sample (Voller et al, 1976, 1977b, and de Savigny and 
Voller, 1980). If a single dilution of the test serum 
is to be used then it is important to select a 
dilution high enough so that the OD readings can be 
made in the effective part of the curive, i.e. at a 
dilution at which high titre serum would fall on the 
upper part of the descending curve (Sherkarchi et al, 
1984). At lower dilutions, the erratic OD readings of 
high titre serum would be difficult to evaluate. 
Therefore, a working dilution of 1/6400 was chosen for 
IgG and 1/400 for IgM. 
The various methods of processing and reporting ELISA 
results have been reviewed by de Savigny and Voller 
(1980), Karpinski et al (1987), Crofts et al, (1988) 
and Parkinson et al (1988). No single method has been 
found to be satisfactory. Bos et al (1976) used serial 
dilutions of the test serum to determine the diagnostic 
titre. They (Bos et al, 1976) compared the OD values 
of the test sera to that of normal serum. Felgner 
(1977) on the other hand, used the OD value of pooled 
healthy sera as the cut-off point for diagnosis. They 
61. 
(Felgner, 1977) considered an OD greater than that of 
the pooled serum as being diagnostic. Agarwal et al 
(1981) used mean OD + 2SD (standard deviation) of 
healthy controls as the cut-off point. Knobloch et al 
(1982), expressed their results as multiples of normal 
activity (MONA). In this dissertation the methods used 
by Agarwal et al (1981), Sakata et al (1985), Lin et al 
(1986) and Gandhi et al, (1987) were used to determine 
the OD cut-off points, i.e. mean + 2 or 3 SD of healthy 
controls. The subject from whom a hookworm sp was 
isolated and who had a positive AGDT was also seropos­
itive with the IgG-ELISA. This subject might have had 
a past unrecognised 1L._ histolytica infection with a 
pathogenic zymodeme, since anti-amoebic antibodies are 
known to persist for several years (Krupp and Powell, 
1971b). 
Having optimised the ELISA to detect specific IgG- and 
IgM-anti-lL.. histolytica antibodies, the sensitivity and 
specificity of the assay needs to be determined and 
evaluated in well documented cases of ALA and appro­
priate control groups. 
CHAPTER A 
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EVALUATION OF THE ENZYME-LINKED IMMUNOSORBENT ASSAY 
(ELISA) IN THE SERODIAGNOSIS OF AMOEBIC LIVER ABSCESS (ALA) 
In an endemic area such as Durban, diagnosis of amoebic liver 
abscess (ALA) is always considered in the differential diag­
nosis of hepatomegaly, especially when the liver is tender 
(Powell et al, 1965 and Adams and MacLeod, 1977). In non-
endemic areas, however, because of the infrequency of ALA, 
the diagnosis of this very treatable disease can be missed. 
A reliable serological test could be used to obviate this 
problem. An important differential diagnosis of ALA is pyo-
genie liver abscess. The latter, especially in endemic 
areas, is less common than ALA and, therefore, may be less 
likely to be diagnosed. The ultrasonography and clinical 
features (toxic pyrexial illness with tender hepatomegaly and 
leucocytosis) in pyogenic liver abscess are similar to ALA. 
These patients' serology for ALA is invariably negative and 
if untreated could have a high mortality. Thus in this 
situation a rapid reliable negative serological test for ALA 
is of value. Even when ALA is diagnosed not all patients 
require aspiration and thus the diagnosis remains presumptive 
(Adams and MacLeod, 1977). If serology in these patients is 
positive, the clinician awaits response to therapy, before 
63. 
deciding whether aspiration should be performed or not 
(delaRey Nel et al 1989). If, on the other hand, amoebic 
serology is negative, another diagnosis is considered and 
aspiration and/or liver biopsy is indicated. Therefore sero­
logical tests for ALA can be of considerable supportive value 
in various clinical situations. Early and rapid diagnosis of 
ALA could improve the outcome of treatment and decrease the 
fatality rate (Adams and MacLeod, 1977). 
Extensive studies in our environment have shown the AGDT test 
to be a sensitive serological test when used routinely in the 
differential diagnosis of ALA. Negative serology not only 
excludes amoebiasis (Powell et al, 1965) but positive serol­
ogy indicates a past or present infection with a pathogenic 
h histolytica (Jackson et al, 1985). Previous comparative 
studies of serological tests with enzyme-linked immunosorbent 
assay (ELISA) systems which detected antibodies to h histo­
lytica of both the IgG class or total immunoglobulin indi­
cated that the assay is more sensitive and specific than the 
other serodiagnostic tests employed in the diagnosis of inva-
sive amoebiasis (Yarig und Kennedy, 1979; nos et al, 
Agarwal et al, 1981, and Baveja et al, 1984). 
1920; 
The ELISA was evaluated for its ability to differentiate past 
from current tissue invasion by h histolytica. The sensit-
64. 
ivity and specificity of the ELISA was evaluated using sera 
from patients with ALA and appropriate control groups. The 
serological response of carriers of pathogenic and non­
pathogenic zymodemes of E....,_ histolytica was also assessed by 
ELISA in an attempt to relate serology to the zymodeme type. 
The assay was compared to the AGDT. 
4.1. MATERIALS AND METHODS 
4.1.1. Antigen 
The h histolytica antigen, a mixture of strains HK9 
and NIH200 with a protein concentration of 9,7mg/ml was 
prepared as described by Jackson et al (1983). 
4.1.2. Serology 
The AGDT and the ELISA were performed as 
Jackson et al (1983) and Sathar et 
respectively. 
4.1.3. STUDY POPULATION 
outlined by 
al (1988), 
Sera from 295 subjects were assayed by the AGDT and the 
ELISA. The study population comprised the following 
groups: 
One hundred (100) patients with confirmed ALA. The 
diagnosis of ALA was made on clinical features, demon­
stration of a liver abscess by ultrasound examination, 
65. 
positive AGDT and a favourable response to rnetroni-
dazole; in addition, bacteriologically sterile pus 
was aspirated from 49 of these patients. Twenty-three 
healthy African subjects who were either University or 
Hospital staff served as controls. They had no clin-
ical evidence of amoebiasis. In addition these sub-
jects had a negative AGDT, as well as negative stool 
microscopy for h histolytica. Also included in the 
study were 121 hospitalized patients with various 
diseases other than amoebiasis, of whom 103 were sero-
negative 
further 
by the AGDT and 8 





diseases and were positive for one or more autoanti­
bodies. In these patients amoebiasis was excluded 
clinically and by a negative AGDT. The 8 patients who 
were AGDT positive.did not have clinical amoebiasis on 
the basis of clinical examination which included sig­
moidsocopy, stool microscopy and ultrasonography of the 
liver. 
Sera from 51 healthy African subjects were obtained 
from a study performed in an area endemic for 
amoebiasis south of Durban (Jackson et al, 1985 and 
Gathiram and Jackson, 1985). The stools of these 
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subjects had been cultured for� histolytica and the 
isolates subjected to isoenzyme electrophoresis to 
determine their zymodemes (Jackson et al, 1985 and 
Gathiram and Jackson, 1985). These subjects were 
grouped into those who were culture negative for fu 
histolytica (n= 30) and those who had pathogenic (n=ll) 
and non-pathogenic (n=l0) zymodemes. 
4.2. RESULTS 
Using an optical density (OD) of 0,250 as the cut-off 
value to separate seropositive from seronegative sera, 
the IgG-ELISA has a sensitivity of 99% and a specif­
icity of 91,7% (Fig. 4.1, page 69). The IgM-ELISA has a 
sensitivity of 64% and a specificity of 97,9% at an OD 
cut-off value of 0,350 (Fig. 4.2, page 69). Comparative 
results of the IgG-ELISA and AGDT and the IgM-ELISA and 
AGDT among the various groups are presented in Table 
4.1 and Table 4.2 (page 70), respectively. 
The AGDT was strongly positive (20 hrs) in all 100 
patients with ALA and the 11 symptomless carriers of 
pathogenic� histolytica, the test was weakly positive 
(40 hrs) in 2 of 10 symptomless carriers of non­
pathogenic zymodemes. Only 8 of 121 hospitalised 
patients were seropositive by the AGDT (Table 4.L). All 
67. 
30 subjects from the endemic area who were culture 
negative for K..,_ histolytica, were seronegative by the 
AGDT (Table 4.1). 
The IgG-ELISA was positive in 99 of 100 ALA patients 
and 10 of 11 symptomless carriers of pathogenic zymo-
demes (Table 4.1). Four symptomless carriers of non-
pathogenic zymodemes were detected by the IgG-ELISA 
(Table 4.1). Six of 30 subjects from the endemic area 
who were culture negative for K..,_ histolytica were posi­
tive by the IgG-ELISA (Table 4.1). In the 121 patients 
without any clinical evidence of amoebiasis, 
seropositive by the IgG-ELISA (Table 4.1). 
12 were 
Sixty-four (64) of 100 patients with ALA and none of 
the 11 symptomless carriers of pathogenic K..,_ histolyt­
ica were seropositive using the IgM-ELISA (Table 4,2). 
One of 10 symptomless carriers of non-pathogenic zymo­
demes were detected by the IgM-ELISA (Table 4.2). One 
of 30 subjects from the endemic area who was culture 
negative for .E....,_ histolytica (Table 4.2)) In the 121
patients without any clinical evidence of amoebiasis, 3 
were seropositive by the IgM-ELISA (Table 4.2). 
68. 
Using Pearson's correlation co-efficient, an excellent 
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The sensitivity of the IgG-ELISA for the diagnosis of 
ALA (99%) is comparable (97-100%) to results reported 
by others (Yang and Kennedy, 1979; Agarwal et al, 
1981; Lin et al, 1981; Tandon, 1981; Mohapatra and 
Sen, 1983; Baveja et al, 1984 and Gandhi et al, 1987). 
The IgM-ELISA is specific for clinical ALA (97,9%) but 
lacks sensitivity (64%). Researchers generally agree 
that titres of IgM-anti-]h_ histolytica antibodies when 
present are less than that of IgG (Boonpucknavig and 
Nairn, 1967; Bray and Harris, 1977 and Osisanya and 
Warhurst, 1980). This seems to indicate that the IgM­
ELISA is unlikely to be of much clinical value until 
its sensitivity is improved. 
In this study a seropositivity of 8,3% was observed 
with the IgG-ELISA in patients without amoebiasis, a 
figure similar to that observed by others with the AGDT 
(Maddison, 1965; Powell et al, 1965 and Maddison et al, 
1965b). This is unlikely to be due to non-specific 
reactions since the IgG-ELISA was negative in patients 
with auto-antibodies and other diseases. However, this 
'background noise' may reflect a past infection with 1h_ 
histolytica as amoebic antibodies are known to persist 
72. 
for several years after treatment (Krupp and Powell, 
1971b). 
Jackson et al (1985) observed that the seropositivity 
of symptomless carriers of pathogenic zymodemes of � 
histolytica were similar to patients with the clinical 
disease. Subjects with a strong positive serological 
reaction were usually associated with a pathogenic zymo­
deme and a negative or weakly positive serological 
reaction was associated with a non-pathogenic zymodeme. 
The positivity of the serological tests in these 
carriers of pathogenic zymodemes is not a non-specific 
response, but indicates subclinical tissue invasion 
(Jackson et al, 1985). Results with the IgG-ELISA in 
cyst passers of pathogenic zymodemes confirm the 
findings of Jackson et al (1985). The IgM-ELISA is 
negative in the majority of subjects from the endemic 
area, possibly indicating an inactive disease. 
A higher seropositivity was observed with the IgG-ELISA 
when compared to the AGDT in hospitalized patients with 
other diseases, in subjects from an endemic area whose 
stools were negative for 1h. histolytica and in symptom­
less carriers of non-pathogenic zymodemes. This could 
be due to the higher sensitivity of the ELISA when 
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compared to other immunodiagnostic tests as has been 
suggested by the work of others (Bos et al, 1980; Lin 
et al, 1981; Agarwal et al, 1981; Gandhi et al, 1986, 
1987 and Proctor et al, 1987). Except for Proctor et 
al (1987) none of these researchers characterised the 
zymodeme of their&... histolytica isolate. This is due 
to the fact that isoenzyme electrophoresis was not 
available to the earlier researchers. The IgG-ELISA is 
as sensitive as the AGDT for the diagnosis of ALA. 
Whilst the sensitivity (99%) and specificity (91,7%) of 
the IgG-ELISA is excellent, the sensitivity of the IgM­
ELISA needs to be improved. The use of more specific 
antigens rather than soluble complex antigens of 1h_ 
histolytica could improve the sensitivity and specif­
icity of the ELISA, (Mathews et al, 1986 and Schulz et 
al, 1987), especially the IgM-ELISA. The different 
amoebic strains used and the methods of preparing the 
antigen could also influence the sensitivity of the 
ELISA. The immunogenicity and specificity of the 
various fractions of&... histolytica are being analysed 
by various researchers (Mathews et 
Ortiz et al, 1986 Joyce and Ravdin, 
al, 1987). 
al, 1986, Ortiz-
1986 and Petri et 
74. 
It is only as regards the speed with which the result 
is provided that this assay would appear to have an 
advantage over the AGDT. The IgG-ELISA results can be 
provided in 2 1/2 hours compared with a minimum of 24 
hours by the AGDT. The prompt availability of the IgG­
ELISA results combined with an improved IgM-ELISA could 
allow the clinical to start specific investigations 
earlier. Early diagnosis and prompt treatment of an 
ALA could reduce morbidity and mortality whilst late or 
misdiagnosis could be fatal (Adams and MacLeod, 1977 
and Editorial, 1978). 
These findings have been published by the South African 
Medical Journal, 1988, 74: 625-628, a copy of which has 
been included in the dissertation. 
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Evaluation of an enzyme-linked immunosorbent 
assay in the serodiagnosis of amoebic liver abscess 
M. A. SA THAR,
V. GA THI RAM,
A. E. SIMJEE, J. DELAREY NEL, 
T. F. H. G. JACKSON 
8. L. F. BREDENKAMP,
Summary 
An indirect enzyme-linked immunosorbent assay (ELISA) was 
evaluated for the detection of anti-amoebic lgG and lgM 
antibodies to assess its value in distinguishing past from 
current infection in invasive amoebiasis, particularly in 
amoebic liver abscess (ALA) patients. Using sera from 295 
individuals, the ELISA was also compared with the amoebic 
gel diffusion (AGO) test. In 100 patients lhe lgG-ELISA al a 
single lest dilution of 1/6400 had a sensitivity of 99% for 
clinically diagnosed ALA. In these same patients the lgM­
ELISA at a single dilution of 1 / 400, had a sensitivity of 64% 
and a specificity of 97,9%. No cross-reactions were observed 
in sera from patients with collagen vascular disease. In 121 
patients without clinical invasive amoebiasis, 8 were AGO­
positive and 12 were lgG-ELISA-positive, giving the faller 
assay a specificity of 91, 7%. This is thought lo be due lo past 
infection with Enlamoeba histolylica. In symptomless carriers 
of pathogenic zymodemes, 10/11 were seroposilive by the 
lgG-ELISA and 11 /11 by the AGO lest. There was an excellent 
correlation between lhe lgG-ELISA and the AGO test (r = 
0,99). The lgG-ELISA is a sensitive, specific, simple and rapid 
test. It has the clinical advantage that results are obtainable 
2½ hours after receipt of the specimen, compared with the 
24 - 48 hours required for the AGO test. The prompt availability 
of lgG-ELISA results could prove advantageous for implemen­
tation of early therapy. The lgM-ELISA was nol found lo be 
sensitive enough lo be used as an index of active amoebic 
infection. 
S Air Mod J 1988. 74: 625-628 
.Walsh' estimated in 1981 that 480 million people harboured 
1:·111m11ocha histoly1iw in their intestinal tracts; in some there is 
intestinal and hepatic invasion.1 Amochia�is is regarded a� the
third most important cause of death from parasites artrr 
malaria and schistosomiasis. 1 
In an endemic area such as Durban, diagnosis of amoebic 
liver abscess (ALA) is always considered in the differential 
diagnosis of hcpatomcgaly, especially when the liver is tender. 
In non-endemic areas, however, because of the infrequency of 
ALA, the diagnosis of this very treatable disease can be 
missed. A reliable serological test could be used to obviate this 
problem. An important differential diagnosis of ALA is 
pyogcnic liver abscess. The latter, especially in endemic areas, 
is less common than ALA and, therefore, may be less likely to 
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be diagnosed. The ultrasonographic and clinical features (toxic 
pyrcxial illness with tender hcpatorncgaly and lcucocytosis) in 
pyogcnic liver abscess arc similar to ALA. These patients' 
serology for ALA is invariably negative and if untreated could 
have a high mortality. Thus in this situation a rapid reliable 
negative serological test for ALA is of value. Even when ALA 
is diagnosed not all patients require aspiration and thus the 
Jiagnosi� remains presumptive. 1 Therefore serological tests for
ALA can be of consiucrablc supportive value in various clinical 
situations. 
Early and rapid diagnosis of ALA could improve the outcome 
of treatment and decrease the fatality rate. 3 With the availability 
of antigen from axcnic cultures of L:". his10/y1ica, emphasis has 
been placed on serological tests as aids in the rapid diagnosis 
of invasive amocbiasis. The various tests used in invasive amoe­
biasis include the indirect hacmagglutination (IHA),' indirect 
lluoresccnt antibody (I f-A),5 counter immuno-clcctrophorcsis
(CIE)," micro-immunoclcctrophoresis (MIE),7 amoebic gel dif­
fusion (AG D}8'9 and latex agglutination (LA). 10 
Extensive studies in our environment have shown the AGO 
test to be a sensitive serological test when used routinely in the 
differential diagnosis of ALA. Negative serology not only 
excludes amocbiasis,9 but positive serology indicates a past or 
present infection with a pathogenic H. his10/y1ica. 11 Previous
comparative studies of serological tests with enzyme-linked 
immunosorbcnt assay (ELISA) systems which detected anti­
bodies to L:". his10/y1ica of both the lgG class or total immuno­
globulin indicated that the assay is more sensitive and specific 
than the other scrodiaPinostic tests employed in the diagnosis
of invasive amocbiasis. 11 
In the search for a test that is sensitive, specific, rapid and 
easy to perform, and that holds the potential of distinguishing 
past from current infection by specifically measuring lgM 
antibodies to/:". hiswzy1ica, we performed a comparative evalu­
ation of the ELISA technique with the AGO test. 
Materials and methods 
Chemicals 
All chemicals were analytical grade. Tris (hydroxmcthyl) 
aminomcthane, polyoxyethylcnesorbitan monolauratc (Tween 
20), peroxidase conjugated immunoglobulin IgG ( y-chain­
spccific goat anti-human lgG) and peroxidase conjugated 
immunoglohulin lgM (µ-chain specific goat anti-human lgM) 
were obtained from Sigma Chemicals (St Louis, Missouri, 
USA). 
Sodium chloride (NaCl), sodium azidc (NaN 3), sodium 
carbonate (Na
2
CO,), hydrochloric acid (HCI) and sodium 
hydrogen carbonate (Nal-ICO 1) were obtained from BOIi 
Chemicals (Poole, England). 
Antigen 
The E. hiswly1ica antigen, a mixture of strains NIH200 and 
HK9, with a protein concentration of 9,7 mg/ml was prepared 
as described prcviously.16 
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Serology 
The AGD test was performed as described by Jackson et 
al. 16
ELISA technique 
The indirect method for the assay of antibodies by ELISA 17
with modifications 18 was used to measure anti-amoebic IgG 
and IgM antibodies. 
Wells of polystyrene microtitre plates, F-form (Dynatech) 
M 129, T & C Scientific Supplies, Durban) were coated with 
amoebic antigen JOO µI and protein concentration 6,25 µglml 
in coating buffer (0,0SM carbonate buffer, pH 9,6) and incu­
bated for 2 hours at room temperature in a humid container. 
Plates were washed with 500 ml of 0,0SM Tris-0,IM NaCl 
buffer (TS) pH 8,0 containing 0,05% (w/v) Tween 20 (TST) 
in a mictotitre plate washer. 19 Washing fluid was shaken off 
and the plates were dried by padding on absorbent material 
(e.g. Softex). Test sera (50 µI) appropriately diluted in TS was 
added to duplicate wells. Plates were incubated for I hour at 
45°C in a humid container. 
Plates were washed with 500 ml of TST, dried, and incubated 
with 50 µI of a 1/1 000 dilution of horse radish peroxidase 
conjugated IgG or IgM in TST for I hour at 45°C. After 
washing, with 500 ml of TST, plates were dried, 50 µI of 
chromogcnic substrate (H202/OPD)1" (Natal 13lood Transfusion 
Services, Durban) was added to each well and plates incubated 
for 5 minutes in the dark at room temperature. The reaction 
was stopped by adding JOO µI of I ,SN HCI. The optical 
density was measured at 492 nm using a Titertck Multiscan 
Micro-ELISA plate reader (Flow Laboratories). 
Study population 
Sera from 295 subjects were assayed by the AGD test and 
ELISA. The study populations (Table I) were as follows: 
(z) 100 patients with confirmed ALA of whom 49 were aspi­
rated, the remaining 51 patients were diagnosed as ALA on
clinical features, ultrasonography and a positive AGD test and
• all responded to metronidazole with complete amelioration of
clinical features; (iz) 23 healthy black subjects who were either
university of hospital staff; (iiz) hospitalised patients with
various diseases other than amocbiasis, of whom I 01 were
negative by the AGO rest and 8 positive; a further 10 had
collagen vascular diseases and were positive for one or more
auto-antibodies (the 8 patients who were AGD positive did
not have clinical amocbiasis on the basis of clinical c:xamination,
which included sigmoidoscopy, stool microsc()py and ultra­
sonography of the liver); and (iv) sera from 51 healthy black
subjects described in an earlier study performed in an endemic
area south of Durban; 11 stools were cultured for E. histoly1ica
and isolates subjected to iso-enzymc-elcctrophoresis to deter­
mine their zymodemes 11 (subjects were grouped into those
who had no amoebae (30) and those who had pathogenic ( 11)
and non-pathogenic (JO) zymodemes).
Results 
Initial experiments using checkerboan.l titrations were per­
formed to optimise the concentrations of the reagents used in 
the assay. The optimal concentration of E. histolytica antigen 
required to coat microtitre plates was found to be 6,25 µg/ml. 
To minimise 'background noise' and to obtain a good discri­
mination between patients and controls, a test dilution of 
1/6 400 was chosen for IgG and 1/400 for IgM. At a cut-off 
point of optical density (OD) 0,250 the IgG-ELISA had a 
sensitivity of 99% and a specificity of 91,7% (Fig. I ). At a cut-
TABLE I. COMPARATIVE RESULTS OF lgG-ELISA AND AGO 
TEST 
Total No. positive 
No. of lgG 
Study groups subjects ELISA AGD 
Amoebic liver abscess 100 99 100 
Healthy hospital staff 23 0 0 
Hospitalised patients with other 
diseases 
AGO-negative 103 4 0 
AGO-positive 8 8 8 
Collagen diseases (with one or 
more auto-antibodies positive) 10 0 0 
Subjects from an endemic area 
No amoeba cultured 30 6 0 
Symptomless carriers of 
£. histolylica 
Pathogenic 11 10 11 
Non-pathogenic 10 4 2 
TABLE II. COMPARATIVE RESULTS OF lgM-ELISA AND AGO 
TEST 
Study groups 
Amoebic liver abscess 
Healthy hospital staff 




Collagen diseases (with one or 
more auto-antibodies positive) 
Subjects from an endemic area 
No amoeba cultured 


























off point of OD 0,350 the Igtrf,ELISA had a sensitivity of 64% 
and a specificity of 97,9% (Fig. 2). As regards the IgM­
ELISA, the greatest difference between patients and controls 
was observed at a dilution of 1/400 with a higher specificity at 
OD 0,350. At lower scrum dilutions of IgM or at a lower OD 
cut-off, both sensitivity and specificity were markedly reduced 
with no observable difference between patients and controls. 
Thus a dilution of 1/400 was chosen. Comparative results of 
IgG-ELISA and AGO, IgM-ELISA and AGO, among the 
various groups are presented in Tables I and II respectively. 
The AG D test was strongly seropositive (20 hours) for all 
JOO patients with ALA, as well as for the 11 symptomless 
carriers of pathogenic E. histolytica and weakly positive ( 40 
hours) in 2/ IO symptomless carriers of non-pathogenic E.
hiswlycica. 
The IgG-ELISA was positive in 99/100 ALA and 10/11 
symptomless carriers of pathogenic zymodemcs (Table I), 
while 64/100 and 0/11 patients with ALA and symptomless 
carriers of pathogenic E. hiscolycica respectively were positive 
by the IgM-ELISA (Table II). Two additional symptomless 
carriers of non-pathogenic zymodemcs were detected by the 
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ALA Auto - Positive Negative Healthy 
antibodies AGD AGD staff 
L---Qther disease• ___J 
Fig. 2. Anti-amoebic lgM results obtained with ELISA. 
The 30 subjects from an endemic environment from whom 
no amoebae were cultured were seronegativc using the AGD 
test. However, 6/30 were positive by the IgG-ELISA (Table 
I) and 1/30 by the lgM-ELISA (Table II).
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In the 121 patients without any clinical evidence of amoe­
biasis, 8 were positive by the AGD test, 12 by the IgG­
ELISA and 3 by the IgM-ELISA. None of the 10 patients 
with collagen vascular disease were positive by any of the three 
tests. 
Using Pearson's correlation co-efficient, we obtained an 
excellent correlation (r = 0,99) between the AGD test and the 
IgG-ELISA. 
Discussion 
The sensitivity of the IgG-ELISA for clinical ALA in this 
study )99%1, is comparable (97- 100%) to those reported by 
others . .1-1i. o-ii The IgM-ELISA appears to be specific for
clinical ALA (97,9%) but lacks sensitivity (64%). Researchers 
generally agree that the detectable anti-amoebic IgM titres arc 
below those of IgG 23-25 and this seems to indicate that the
assay is unlikely to be of much clinical value until its sensitivity 
is improved. 
What then is the place of the lgG-ELISA in the diagnosis 
of ALA and in particular, how docs it compare with the AGD 
test? In the past 20 years, the AG D test has proved a very 
reliable and inexpensive test for the diagnosis of ALA. The 
test is invariably negative in those patients who do not have 
ALA. Therefore, a negative result with the AGD rules out 
invasive amocbiasis and thus another diagnosis needs to be 
considered. Positive serology indicates that the abscess may be 
due to E. histolytica, but in our endemic area 10- 15% of 
individuals with no clinical evidence of invasive amocbiasis arc 
scropositivc using the AGD tcsr.M·•·26 This is thought to be due 
to past infection with E. histolytica since amoebic antibodies 
arc known lo persist for long periods after successful trcatmcnt.7 
We observed a scropositivity of 8,2% with the IgG-ELISA, a 
figure similar to that observed by othcrs_x.Y,2<, This was not 
thought to he due to nonspecific reactions since the IgG­
ELISA was negative in patients with auto-antibodies. Sero­
logical tests arc positive in invasive amocbiasis both in amoebic 
<lyscntcryx and ALA.'' It is necessary to comment on a positive 
test in asymptomatic carriers of pathogenic zymodcmcs. We 
feel that the work of Jackson et al. 11 has shown that the 
positivity of the test is not a nonspecific response, but appears 
to indicate subclinical invasion. Thus these patients arc included 
under invasive amochiasis. 
A higher scropositivity was observed with the IgG-ELISA 
when compared with the AG D test in hospitalised patients 
with other diseases, in subjects from an endemic area whose 
stools were negative for E. histolytica, and in symptomless 
carriers of non-pathogenic zymodcmes. This could be due to 
the higher sensitivity of the ELISA when compared with 
other immunodiagnostic tests for ALA as has been suggested 
by the work of others, 1 i-i i.io-n or it could reflect a nonspecific
background noise. 27 If indeed it is the latter, it makes the IgG­
ELISA a less suitable test than the AGD. However, the 
immunogcnicity and specificity of the various fractions of the 
amoebic antigen arc still matters of speculation. 28-32 The dif­
ferent amoebic strains used and the methods of preparing the 
antigen could influence the sensitivity of the tests. Whether 
the antibodies detected by ELISA arc similar or different 
from that detected by the AGD test has not been dctcr­
mincd.14· 11 
Elsdon-Dcw ct al. JJ emphasised 'a need for a simple, quick 
test' and stated that 'the AG D test suffers from one clinical 
disadvantage ... one cannot report an unequivocal negative 
reaction in less than 48 hours'. 
. The late)( agglutination test (Seramcba) was developed to 
aid the rapid diagnosis of ALA,10 giving an answer within 30
minutes, but the disadvantage was its high cost.3':35 The IgG­
ELISA is rapid and simple. It is only as regards the speed 
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with which the result is provided that this assay would appear 
to have an advantage over the AGO test. IgG-ELISA can be 
provided in 2½ hours compared w:th a minimum of 24 hours 
hy the AGO test. The prompt availahility of the lgG-ELISA 
results could allow a dinician to �tart specific investigations 
and treatment earlier. 
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CHAPTER 2 
SPECIFIC IgG- AND IgM-ANTIBODY RESPONSE TO 
ENTAMOEBA HISTOLYTICA (HK9) SOLUBLE AND 
MEMBRANE FRACTIONS 
75. 
Generally, the tendency has been to use soluble complex 
antigens derived from the whole amoebae when evaluating the 
ELISA. For invasiveness to occur direct contact of E.._._ histo­
lytica trophozoites with the host's cells is necessary 
(Ravdin, 1989); and surface or plasma membrane antigens would 
be the first to interact with the hosts immune system. 
Therefore, it would seem logical to use these antigens in 
sero-diagnostic tests, especially in the ELISA. 
The difference in sensitivities between the IgM-ELISA (Sathar 
et al, 1988) and the IgM-IFAT (Jackson et al, 1984) may be 
due to differences in the physical state of the antigen used. 
In the former assay IgM antibodies were detected to soluble 
complex antigens compared to insoluble, whole parasite 
surface antigens in the latter assay. Whilst the interpreta­
tion of immunoflourescence, especially that of IgM-IFAT is 
subjective, the IgM-ELISA using soluble complex antigens of 
E.._._ histolytica is not sensitive enough (64%) to determine 
current infection (Sathar et al, 1988). Using the ELISA to 
detect specific E.._._ histolytica antibodies in studies with a 
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limited number of ALA patients (2-4), serologically active 
antigens have been shown to be associated with the plasma 
membrane (Mathews et al, 1986 and Schulz et al, 1987). These 
limited studies show that surface or plasma membrane antigens 
of .E....._ histolytica may have a role to play in the ELISA. 
This study was performed in order to determine whether the 
use of membrane or other subcellular fractions of .E....._ histo­
lytica as antigens, would improve the diagnosis potential of 
the IgM-ELISA. 
5.1. MATERIALS AND METHODS 
Forty-eight (48) hour cultures of .E....._ histolytica strain 
HK9 grown axenically were obtained from the RIDTE, 
Durban. Separation of the amoeba into its subcellular 
fractions was performed by the method described by Aley 
et al (1980). Each fraction was solubilised by the 
method described by Mathews et al (1986). 
The protein content of the various fractions were 
determined by the Lowry method (1951) using human serum 
albumin (HSA) (Sigma Chemicals Co., St. Louis, MO) as 
the standard. The antigens were stored frozen at -20
°
C 
in l00ul aliquots. These aliquots were used once only 
and were not repeatedly thawed or frozen. 
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5.1.2. Serology 
AGDT was performed according to the method described 
by Jackson et al (1983). The ELISA (Sathar et al, 
1988) was used to determine the specific IgG and IgM 
response of each membrane and soluble fraction of fu 
histolytica. 
To reduce the NSB to acceptable levels when plasma 
membranes and internal membranes were used as the 
antigen in the IgM-ELISA; the test sera were diluted 
in 3% (w/v) gelatin (Biorad Laboratories, California) 
Tris saline (TS). To further reduce any possible non­
specific binding of the conjugate, F(ab')2 fragment of 
the enzyme conjugate was used (goat-anti-human IgM u­
chain specific, F(ab')2 fragment, Sigma Chemicals, St. 
Louis, MO, USA). 
5.1.3. Study Population 
Positive control sera were obtained from two patients 
with amoebic liver abscess (ALA) who were clinically 
diagnosed by ultrasonography, aspiration of sterile 
pus, positive AGDT (20 hr) and a favourable response to 
metronidazole. A negative control serum was obtained 
from a volunteer of the University staff who had no 
clinical evidence of amoebiasis and whose AGDT and 
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stool microscopy for� histolytica were negative. The 
sera were tested at a single serum dilution of 1/100. 
5.2. RESULTS 
The protein concentrations in the various fractions 
were as follows: soluble fraction, 210ug/ml; plasma 
membrane, 164ug/ml; internal membranes, 160ug/ml and 
non-vesiculated membranes and debris, 120ug/ml. The 
protein content of the standard antigen was 9,7mg/ml. 
The data obtained with the IgM-ELISA using soluble, 
plasma membrane, internal membrane and vesiculated 
membrane fractions as the antigens are reported here. 
The IgM titration curves of the negative and the two 
ALA sera obtained with the various antigens for the 
IgM-ELISA are shown in Figures 5.1 - 5.4 (page 80) and 
Fig. 5.5 (page 81)� As can be seen from these fig­
ures, serum A was more reactive than serum B with each 
antigen preparation. Another common feature in all of 
the antigen fractions is the rather high non-specific 
binding (NSB). This is lowest in the standard antigen 
(Fig. 5.1), nevertheless, it is considerably higher 
than that reported elsewhere (Fig. 3.1, page 47), and 
highest in the case of non-vesiculated membrane and 
debris (Fig. 5.5, page 81). In the case of the soluble 
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fraction (Fig.5.2), the plasma membrane (Fig. 5.3) and 
the internal membrane (Fig. 5.4), the high NSB did not 
prevent a clear distinction between the positive sera 
and the negative control. However, particularly fav­
ourable titration curves were observed with the plasma 
membrane antigen (Fig. 5.3) and the internal membrane 
antigen (Fig. 5.4). Due to the higher NSB observed 
with non-vesiculated membranes and debris in the IgM­
ELISA (Fig 5.5, page 81) this fraction was not further 
investigated. 
Following the use of 3% gelatin and the F (ab')2 frag­
ments of the conjugate the NSB was reduced to accept­
able levels in the IgM-ELISA using plasma membranes or 
internal membranes of E...,_ histolytica as the coating 
antigens (Figs 5.6 and 5.7, page 81, respectively). 
The optimum concentration of the plasma membrane anti­
gen was deemed to be that which gave minimal signal to 
noise ratio. To conserve antigen, a protein concen­
tration of 5ug/ml of plasma membrane antigen was con­
sidered optimal for the IgM-ELISA (Fig. 5.6). 
AU\ 
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There was no added advantage in using the plasma mem­
brane or soluble fractions of h histolytica in the 
IgG-ELISA. On the contrary, using the soluble complex 
antigen derived from ruptured h histolytica (Chapter 
4) gave excellent sensitivity (99%) and specificity 
(92%). Therefore, the use of this antigen to detect 
IgG-anti-h histolytica antibodies with the ELISA is 
adequate. 
In preparing the standard soluble antigen, the insol­
uble material is discarded (Jackson et al, 1983). This 
insoluble material contains the membrane fractions of 
h histolytica. The soluble antigen preparation used in 
the ELISA previously, (Chapter 4) may not have included 
sufficient antigens to detect specific IgM-anti-h 
histolytica antibodies. The improved titration curves 
observed with the the IgM-ELISA when the plasma mem­
brane fraction was employed as the antigen, may be due 
to more IgM-epitopes being available to react with IgM 
antibodies. Sufficient quantities of the antigen may 
have been bound to the solid phase, therefore, 
reacting more strongly. 
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Previously, the exclusion of bovine serum albumin (BSA) 
(Fig. 3.10 page 50) in the IgM-ELISA improved the 
specificity of the assay. In this experiment the 
addition of 3% gelatin as a blocking agent (Vogt et al, 
1987) in the serum diluent (TS) reduced NSB of the 
negative control serum. In addition, the use of the 
F(ab')2 fragments of the enzyme conjugate would appear 
to have minimised NSB (Fig 5.3 vs Fig.5.6, and Fig 5.4 
VS Fig 5.7). 
The reactivity of the sera to the internal and plasma 
membrane fractions (Figs 5.3 and 5.4, and Figs 5.6 and 
5.7) were similar. This is in keeping with current 
thinking that E...e_ histolytica is constantly turning over 
its plasma membrane, interchanging its outer membrane 
with fresh internal membrane (Aley et al, 1980; Aust­
Kettis, 1983 and Mathews et al, 1986). Recently, 
Ostoa-Saloma et al (1989) provided further support for 
the rapid membrane turnover theory. These researchers 
used the method of Aley et al (1980) to fractionate .E...,_ 
histolytica into different subcellular fractions to 
determine the subcellular locations of proteolytic 
enzymes. Their results suggest that the proteinase 
composition of the internal vesicles and internal mem-
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branes are similar to that of the plasma membrane 
(Ostoa Saloma et al, 1989). 
Contact by Entamoeba histolytica with the host's cells 
is a prerequisite for invasiveness (Ravdin, 1989). 
Therefore, a reasonable inference is that surface or 
membrane antigens have an important role to play in 
the ontogeny of an immune response to the invading 
organisms. Consequently, a great deal of attention has 
been focussed on the antigens of the surface membrane 
of .E...,_ histolytica. 
At the time of writing this dissertation no single 
antigen has been identified as having greater diagnos-
tic potential than any other. Indeed it is probable 
that most, if not all the antigens identified as being 
immunogenic on the surface of .E...,_ histolytica (Meza et 
al, 1987; Joyce and Ravdin, 1988; Petri et al, 1989; 
Torian et al, 1989 and Reed et _tl, 1989) are present in 
the plasma membrane fraction used in the study 
described in this Chapter. In addition, the fact that 
good yields of the plasma membrane fraction can be 
produced by a relatively simple, differential centri­
fugation (Aley et al, 1980), as opposed to the elab-
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orate purification schemes described by others (Meza et 
al, 1987; Torian et al, 1987 and Petri et al, 1987), 
leads one to conclude that the plasma membrane fraction 
is entirely adequate for use in a practical ELISA for 
detecting specific IgM-antibodies to invading .E....,_ histo­
lytica. In addition, the sensitivity of the serodiag­
nostic test may be enhanced by monitoring the immune 
response to a number of antigens (plasma membrane) 
rather than to any one antigen. 
Although future research may identify a unique and 
exceptionally potent antigen, it is questionable 
whether it would find application in serodiagnosis in 
the field, in view of the likely high cost. In Third 
World Laboratories where funds are limited and First 
World technology is absent, it may be more economical 
to use the plasma membrane fraction in the ELISA. 
Evaluation of the ELISA to detect specific IgG- and 
IgM-anti-.E....,_ histolytica antibodies using a plasma mem­
brane fraction has been limited (Mathews et al, 1986 
and Schulz et al, 1987). These researchers investi­
gated 2 and 4 ALA patients, respectively. The results 
of these limited studies suggest that the assay needs 
to be evaluated in a more comprehensive study using 
86. 




DETECTION OF Entamoeba histolytica IMMUNOGLOBULINS 
G AND M TO PLASMA MEMBRANE ANTIGEN BY ENZYME-LINKED 
IMMUNOSORBENT ASSAY 
In areas where inavsive amoebiasis is not endemic (Stamm et 
al, 1976), the detection of specific IgG-anti-1,L_ histolytica 
antibodies would be considered to be diagnostic of current 
amoebic infection. On the other hand, in areas endemic for 
invasive amoebiasis, detecting specific IgM-anti-1,L_ histo­
lytica antibodies would be more useful in determining whether 
or not there is active/current amoebic infection. Most 
ELISAs used in diagnosing invasive amoebiasis have measured 
either specific IgG or total immunoglobulins. These anti­
bodies have been detected to soluble, complex antigens of 1,L_ 
histolytica. The ability of the ELISA to detect specific 
IgM-anti-1,L_ histolytica antibodies in endemic areas of amoe­
biasis is not sensitive (64%) enough to differentiate past 
from current invasive amoebiasis (Sathar et al, 1988). 
Another approach to improve the diagnostic potential of sero­
logical tests would be to use specific antigens of 1,L_ histo-
lytica. The antigen preparations used to date have been 
highly complex and of a poorly defined composition (Yang and 
Kennedy, 1979; Agarwal et al, 1981; Bos et al, 1980; 
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Mohapatra and Sen, 1983; Gandhi et al9, 1987 and Sathar et 





histolytica antibodies, observed that the immune 
ALA patients recognized specific antigens 
with the plasma membrane of h histolytica. 
Schulz et al (1987) using antigens derived from monoaxenic 
cultures of h histolytica showed that the IgM antibodies of 
one ALA patient reacted with a 10-15 KDa protein component of 
the plasma membrane. These limited studies show that spec­
ific antigen preparations of h histolytica may play a signi­
ficant role in the detection of specific antibodies in the 
serodiagnosis of invasive amoebiasis. 
In this study, the plasma membrane of E...:._ histolytica was 
used as the antigen in the enzyme-linked immunosorbent assay 
(ELISA) to detect specific IgG and IgM antibodies in serum 
samples obtained from 61 subjects. 
6.1. MATERIALS AND METHODS 
6.1.1. Antigen 
The plasma membrane of axenically cultured h histo­
lytica strain HK9 was isolated by the methods of Aley 
et al (1980). 
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6.1.2. Serology 
The performance of the ELISA was similar to that of 
Sathar et al (1988), except for two modifications, 
viz: 
i) The test sera were diluted 1/100 in 3%-Gelatin 
(Bio-Rod Laboratories, Richmond, California) 
Tris Saline (TS).
ii) F(ab')2 fragments (Sigma Chemical Co., St. Louis,
MO, USA) of horseradish peroxidase conjugated goat
anti-human IgG (gamma-chain specific) and IgM (mu­
chain specific) were used as the developing anti­
bodies.
The AGDT was performed as described by Jackson et al
(1983). 
6.1.3. Study Population 
Serum samples from 61 subjects were collected and 
stored in aliquots of 200ul at -20
°
C. All sera tested 
were thawed once only to detect specific IgM and IgG 
antibodies using the ELISA. All sera were coded and 
tested. The study population included the following 
subgroups: 
i) Twenty-two (22) patients with ALA. The diagnosis 
was made on the basis of clinical features, 
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ultrasonography, a positive AGDT, a favourable 
response to metronidazole and aspiration of 
sterile pus from 10 patients. 
ii) Twelve (12) healthy volunteers employed at the 
University of Natal or King Edward VIII Hospital 
who had no clinical evidence of amoebiasis. 
Their sera were negative for anti-.E__._ histolytica 
antibodies by the AGDT and their stools were 
negative for .E__._ histolytica on microscopy. 
iii) Ten (10) hospitalised patients from the medical 
wards of King Edward VIII Hospital with various 
diseases other than amoebiasis. Amoebiasis was 
excluded by the absence of clinical symptoms and 
a negative AGDT. 
iv) Seventeen (17) healthy subjects from an area 
endemic for .amoebiasis; the AGDT response of 
these subjects had been determined previously 
(Jackson et al, 1985). Single stool samples from 
all subjects were cultured in Robinson's culture 
medium (Robinson, 1968) and in those cases where 
.E__._ histolytica was isolated the zymodeme, patho­
genic or non-pathogenic, was determined by 
previously described methods (Gathiram and 
Jackson, 1987). In six (6) of 17 subjects, .E__._ 
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istolytica could not be cultured from the stool 
samples; three (3) were AGDT positive and three 
(3) AGDT negative. There were six (6) asympto­
matic carriers of non-pathogenic 1h histolytica, 
two (2) of whom were AGDT positive and four (4) 
AGDT negative; the remaining five (5) were 
asymptomatic carriers of pathogenic 1h histo­
lytica, all of whom were AGDT positive. 
6.1.4. Statistical Analysis 
Pearson's correlation co-efficient was used to deter­
mine the correlation between the AGDT and the ELISA. 
The Student t-test was used to determine the difference 
in OD values between the different study groups. 
6.2. RESULTS 
The criteria established previously (Chapter 3), were 
used to determine the absorbance cut-off between sero­
positive and seronegative results, i.e. mean + 2SD 
(standard deviation) and mean + 3SD of normal healthy 
controls for IgG and IgM, respectively. A single serum 
dilution of 1/100 was used for all samples tested. An 
absorbance value of 0,250 for IgG and 0,200 for IgM was 
used as the cut-off to separate seropositive from sero­
negative samples. 
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Distribution of individual results obtained with the 
IgG- and IgM-ELISA for the various groups are represen­
ted in Figs. 6,1, 6.2 and 6.3, page 95 respectively. 
All healthy controls were seronegative by the IgG- and 
IgM-ELISA as well as the AGDT. Nineteen (19) of the 20 
patients (95%) with ALA were seropositive by the IgG­
ELISA (Fig. 6.1) and in 18 (90%) the IgM-ELISA gave 
positive results (Fig. 6.2). Two (2) patients with ALA 
had a negative AGDT at the time of admission to the 
hospital; both of them proved to be seropositive by 
the IgG-ELISA (Fig 6.1) , and in one of them, the IgM­
ELISA was also positive (Fig 6.2). There was a signif­
icant difference (P < 0,001) in the OD values between 
ALA patients and normal healthy controls with the IgG­
and IgM-ELISA. No significant difference was observed 
between the latter group and hospitalised patients with 
other disease�. 
The distribution of absorbance values obtained with 
IgG- and IgM-ELISA on sera obtained from asymptomatic 
subjects from an area endemic for amoebiasis 
resented in Fig. 6.3. All culture-negative 




the highest absorbance (A.492nm) values were observed 
93. 
from the three (3) cases who were also positive by the 
AGDT. The IgM-ELISA was positive in only one of the 
culture-negative controls. All 5 carriers of patho­
genic zymodemes were seropositive by the IgG-ELISA; 
however, none of these subjects was seropositive by 
IgM-ELISA. Only one of six (6) sera from carriers of 
non-pathogenic 
IgM-ELISA; of 
zymodemes proved to be positive by the 
the three (3) subjects who were IgG-
ELISA positive, two (2) also had a positive AGDT. Of 
the 10 hospitalized patients without clinical evidence 
of amoebiasis, two were positive by the IgG-ELISA (Fig. 
6.1) and the one by IgM-ELISA (Fig. 6.2). No signifi­
cant difference in the OD values were observed between 
normal healthy controls and subjects from an endemic 
area with the IgM-ELISA. However, there was a signifi­
cant difference (P.< 0,02) in the OD values obtained 
with the IgG-ELISA between normal healthy controls and 
subjects in whom 1L._ histolytica could not be cultured 
from their stool. There were also significant differ­
ences between normal healthy controls and asympto­
matic individuals with pathogenic (P <0,001) and non­
pathogenic (P < 0,05) zymodemes. There was an 
excellent correlation between the IgG-ELISA and AGDT 
(r=0,96). The IgG- ELISA had a sensitivity of 95% and 
94. 
a specificity of 91%; the IgM-ELISA had a sensitivity 
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6.3. DISCUSSION 
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Previously reported studies using the ELISA to diagnose 
invasive amoebiasis employed poorly defined soluble 
antigens of h histolytica (Yang and Kennedy 1979 and 
Bos et al, 1980). This is the first study in which the 
solubilised plasma membrane of h histolytica was used 
in an ELISA to detect specific IgG- and IgM-antibodies 
in a large group of well-documented cases of clinic-
ally diagnosed ALA patients and appropriate control 
groups, including asymptomatic carriers of pathogenic 
and non-pathogenic amoebae. 
Use of the plasma membrane antigen of h histolytica 
did not improve the sensitivity of the IgG-ELISA (95%) 
compared to that reported with soluble, complex anti­
gen (99%) (Chapter 5). Further purification of the 
whole, soluble extract of h histolytica would be of no 
further advantage in improving the sensitivity of the 
IgG-ELISA. By contrast, use of the plasma membrane 
antigen in the ELISA to detect specific IgM-anti-h 
histolytica antibodies effectively improved the sensi­
tivity of the IgM-ELISA from 64% (Chapter 4), to 91%. 
In comparison to a sensitivity of 68% reported by 
Torian et al (1989) and 80% reported by Reed et al 
97. 
(1989), the higher sensitivity (95%) of the IgG-ELISA 
in this study in diagnosing ALA may be due to the 
presence of some, if not all of the specific, multiple 
defined K.,_ histolytica surface antigens (37 KDa-220 
KDa) which have been isolated by other researchers 
(Meza et al, 1987; Petri et al, 1987 and 1989; Torian 
et al, 1989; Joyce and Ravdin, 1988 and Reed et al, 
1989) rather than to the absence of any one antigen. 
The success of the IgM-IFAT (Jackson et al, 1984) in 
distinguishing past from current amoebic infection 
was due to the detection of specific IgM-antibodies to 
insoluble surface antigens of K.,_ histolytica. The 
improved sensitivity (91%) of the IgM-ELISA in the 
present study is due to the detection of specific IgM 
antibodies directed to epitopes on the surface mem­
brane. 
Occasionally, the AGDT is either weakly positive (40 
hr) or negative for ALA patients on admission; this is 
thought to be due to inadequate antibody production 
(Jackson et al, 1985), since the AGDT invariably 
becomes positive when repeated a few days after 
hospital admission (Powell et al, 1965; Krupp and 
Powell, 1971a and Gathiram et al, 1989). Interest-
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ingly, the IgG-ELISA of the two ALA patients whose 
AGDTs were negative on admission, were positive. The 
IgM-ELISA was positive in one ALA patient and negative 
in the other. When the AGDT was repeated five days 
later, it was seropositive in both these patients. The 
IgG and IgM-ELISA in both these patients were positive 
on the repeat blood samples (data not shown). With the 
ELISA a current diagnosis would have been confirmed. 
This clinical advantage of the ELISA could be useful in 
the early diagnosis and treatment of ALA. 
The higher seropositivity observed with the IgG-ELISA 
compared to the AGDT in hospitalised patients with 
other diseases is due to the higher sensitivity of the 
ELISA compared to other serodiagnostic tests (Yang and 
Kennedy, 1979; Bos et al, 1980; Agarwal et al, 1981 and 
Knobloch and Mannweiler, 1983), and it reflects a past 
infection with .E....._ histolytica, as amoebic antibodies 
are known to persist for several years after treatment 
(Krupp and Powell, 1971b and Joyce and Ravdin, 1988). 
The serological responses of asymptomatic subjects are 
interesting. The asymptomatic carriers of pathogenic 
zymodemes all produce IgG antibodies to the surface 
membrane of .E....,_ histolytica, suggesting that these indi-
99. 
victuals have at some stage experienced subclinical 
tissue invasion. The seropositivity (AGDT and IgG­
ELISA) of asymptomatic carriers of pathogenic zymodemes 
(100%) is not significantly different to that of 
patients with clinically active disease (ALA) (91%-
95%). In the former group of individuals, the absence 
of an IgM response would indicate inactive disease, 
compared to a positive IgM response in patients with 
active disease (ALA). The specificity of the IgM-ELISA 
for excluding active disease is indicated by the neg­
ative serological responses obtained from the sera of 
healthy carriers of non-pathogenic zymodemes and 
culture negative controls from the endemic area. The 
positive results obtained by the IgG-ELISA in culture 
negative controls and carriers of non-pathogenic zymo­
demes possibly indicate past infection with pathogenic 
zymodemes, confirming that the ELISA may be a more 
sensitive test than the AGDT for the diagnosis of past 
infection. 
Recently it was shown that more than one-third of ALA 
patients continue to pass cysts of pathogenic� histo­
lytica following successful treatment; there was 
recurrence of symptoms in some with high antibody tit-
100. 
res (AGDT) (Irusen et al, 1989). It would be interes­
ting, therefore, to monitor the IgG and IgM antibody 
response of asymptomatic cyst passers of pathogenic 
zymodemes, using the ELISA, during an extended follow­
up study. The ELISA could prove useful, since the 
seropositivity (IgG-ELISA and AGDT) of asymptomatic 
carriers of pathogenic zymodemes is comparable to ALA, 
whilst the IgM-ELISA in the former, is negative. Thus 
while the IgG-ELISA like the AGDT would be of import­
ance in ascertaining the prevalence of pathogenic zymo­
demes in the community, inclusive of past and present 
infections, (the interpretation of which must be made 
with caution), the sensitivity (91%) and specificity 
(95%) of the IgM-ELISA would make it of value for 
diagnosing current tissue invasion by E..,_ histolytica. 
These findings have been published by the Journal of 
Clinical Microbiology 1990; 28; 332-335, a copy of 
which has been included in the dissertation. 
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1990, p. 332-335 
0095-l 137/90/020332-04$02.00/0 
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Sixty-one serum specimens from 22 patients with clinically diagnosed amoebic liver abscess (ALA), 10 
hospitalized patients with a variety of diseases other than amoebiasis, 12 normal healthy controls, and 17 
subjects from an amochiasis-cndemic area were assayed by enzyme-linked immunosorbcnt assay (ELISA). The 
plasma membrane fraction of axcnic cultures of E11tamoeba histolytica IIK9 separated from other subcellular 
fractions by differential centrifugation was used as the antigen to detect specific immunoglobulin G (IgG) and 
IgM antibodies. Using a single serum dilution of 1/100 and optical densities at 492 nm of 0.200 and 0.250 as the 
cutoff values for the IgM and lgG ELISAs, their respective sensitivities in 22 ALA patients were 9 l % (20 of 22) 
and 95 % (21 of 22). In 22 patients ( JO hospitalized and 12 normal healthy controls), the specificities of the lgM 
and lgG ELISAs were 95% (21 of 22) and 91 % (20 of 22), respectively. All five asymptomatic carriers of 
pathogenic E. histolytica were seropositivc by the lgG ELISA and the amoebic gel diffusion test (AGOT). The 
AGDT was positive for three of six culture-negative controls, while the lgG ELISA was positive for all six. For 
six asymptomatic carriers of nonpathogenic zymodemcs, the AGDT was positive for two, and the lgG ELISA 
was positive for three. There was an excellent correlation (r = 0.96) between the lgG ELISA and the AGDT. 
Only one of six culture-negative control,·, none of the asymptomatic carriers of pathogenic E. histolytica, and 
one of six carriers of nonpathogenic £ histolytica were seropositive by the IgM ELISA, thus highlighting the 
s1>ecificity of the lgM ELISA in the diagnosis of ALA. It is believed that the use of plasma membrane fractions 
has improved the diagnostic potential of the lgM ELISA. 
The measurement of specific immunoglobulin M (lgM) 
antibodies is valuahlc in distinguishing current and past 
infections in giardiasis (7) and toxoplasmosis (18). Antibod­
ies to E11ta111oeha liistolytica have been shown to persist for 
at least 3 years after cure of amoebic liver abscess (ALA) 
(11). At present, there is no serological test that can reliably 
distinguish active from past tissue invasion by this parasite. 
The amoebic gel diffusion test (AGDT) is a sensitive test for 
ALA and is positive in 96% of cases (20). However, a 
positive AGDT is given by 15 10 20% of the population of the 
amocbiasis-endcmic areas around Durban who have no 
evidence of active amoebiasis and is thus of limited value in 
distinguishing current infection (10). A previous study of the 
specific lgM response using the indirect immunonuorcsccnt­
antibody test showed it to be of some value in diagnosing 
current infection, since the IgM antibody response lasted 
approximately 6 months (8). We have previously reported 
that the measurement of specific lgM antibodies by an 
enzyme-linked immunosorbcnt assay (ELISA) technique 
that employed soluble antigens of£. histolytic:a was specific 
(97 .9%) but lacked sensitivity (64%) (24). Monitoring specific 
circulating antigen of £. liistolytica is of particular impor­
tance; it would allow a more accurate assessment of the 
infection process than docs the detection of antibodies, but 
this requires further evaluation (5, 17). Direct contact of£. 
histolytica trophozoitcs and host cells is necessary for inva­
siveness (21). Thus, it seems logical that surface membrane 
or plasma membrane antigens would be the first to interact 
with the host immune system during infection and thereby 
* Corresponding author.
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might constitute the major component in the serological 
rcspom,c. By using an ELISA to detect specific IgG-£. 
histolytica antibodies, serologically active antigens have 
been shown to be associated with the plasma membrane (15). 
In the present study, the plasma membrane fraction of 
axcnically cultured £. histolytic:a was used as the antigen in 
an attempt to improve the diagnostic potential of the lgM 
ELISA. 
MATERIALS AND METHODS 
Antigen preparation. The contents of several simulta­
neously grown tubes of 48-h axenically cultured £. histolyt­
irn H K9 were harvested and pooled. The packed cells from 
the final wash were counted and appropriately diluted to give 
2.5 x 107 cells per ml of bufTer (1). 
The plasma membrane fraction of E. histolytica HK9 was 
obtained by differential centrifugation (1). BricOy, washed 
trophozoites were incubated with concanavalin A. This 
stabilized the plasma membranes as large sheets, facilitating 
separation by dif
f
erential centrifugation. Dissociation of 
concanavalin A with o:-methyl-o-mannopyranoside followed 
by additional homogenization vesiculated the plasma mem­
branes. This preparation was solubilized (15), and its protein 
concentration was determined (14). 
Study population. Scrum samples from 61 subjects col­
lected on hospital admission over a period of about 2 years 
were stored in aliquots of 200 µI al -20°C. All scra tested 
were thawed once only to detect specific lgM and lgG 
antibodies by using the ELISA method (24); all sera were 
tested in a blind coded manner. The study population 
included the following subgroups. (i) Twenty-two patients 
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with ALA. The diagnosis was made on the basis of clinical 
features, ultrasonography, a positive AGDT, a favorable 
response to metronidazole (24), and aspiration of sterile pus 
from 10 patients. (ii) Twelve healthy volunteers employed at 
the University of Natal or King Edward VIII Hospital who 
had no clinical evidence of amoebiasis and whose AGDTs 
and stool microscopies were negative for£. histolytica. (iii) 
Ten hospitalized patients with various diseases other than 
amoebiasis. Amoebiasis was excluded by the absence of 
clinical symptoms and a negative AGDT. (iv) Seventeen 
healthy subjects from an amocbiasis-cndcmic area; the 
AGDT responses of these subjects had been determined 
previously (10). Single stool samples from all subjects were 
cultured in Robinson culture medium (22), and in those cases 
in which £. histolytica was isolated, the zymodcmc (patho­
genic or nonpathogenic) was determined by a previously 
described method (6). For six subjects £. histolytica could 
not be cultured from the stool samples; three were AGDT 
positive, and three were AGDT negative. There were six 
asymptomatic carriers of nonpathogenic E. histolytica, two 
of whom were AGDT positive and four of whom were 
AGDT negative; the remaining five were asymptomatic 
carriers of pathogenic£. histolytica, and all five ·,,vcre AGDT 
positive. 
lgG and lgM ELISAs. The ELISA was a modification of 
that used previously (24). Wells of F-form polystyrene 
microtiter plates (Dynatech Ml29; T & C Scientific Supplies, 
Durban, South Africa) were coated with 100 µI of 0.05 M 
carbonate-bicarbonate (Na2COrNal-lCO3) buffer, pH 9.6, 
which contained a protein concentration of 5 µg of plasma 
membrane antigen per ml. Antigen-coated plates were used 
immediately. Plates were incubated for 2 h at room temper­
ature in a humid container. They were washed with 300 ml of 
0.05 mM Tris-0.1 M NaCl buffer (TS), pH 8.0, containing 
0.05% (wt/vol) Tween 20 (TST), followed by 200 ml of 
glass-<listilled water. At each wash, microtitc1· plate,-, wc1c 
flooded with an excess of wash fluid in a specially con­
structed ELISA shower (Natal Blood Transfusion Services, 
Durban, South Africa) (4). TST was shaken off, and the 
plates were dried by padding them onto absorbent material. 
Test sera (50 µI) diluted 1/100 in 3% gelatin (Bio-Rad 
• Laboratories, Richmond, Calif.)-TS were added to duplicate
wells. Plates were incubated for l h at 45°C in a humid
container and washed with 500 ml or TST. Fifty microlilcrs ·
of a 1/1,000 dilution of horseradish peroxidase-conjugated
goat anti-human lgG (-y-chain specific) or lgM (µ-chain
specific) F(ab')i fragments (Sigma Chemical Co., St. Louis,
Mo.) in TST was added, and plates were incubated at 45°C
for l h. After being washed with 500 ml of TST, the plates
were dried, and 50 µI of chromogenic substrate (3) (18.4 mM
sodium borate, 30.5 mM succinic acid, 3.77 mM O-phenyl­
cnediamine, 4.0 mM hydrogen peroxide, pH 5.0) was added
to each well. The plates were then incubated for 5 min in the
dark at room temperature. The reaction was stopped by the
addition of 100 µl of 1.5 N HCI. The optical density (OD)
was read at 492 nm by using a Titcrtek Multiskan Plate
Reader (Flow Laboratories, Inc., McLean, Va.). Selection
of the optimal test dilution (1/100) was based on titration
curves derived from data based on serial twofold dilutions of
positive (ALA) and negative (normal healthy) control sera.
The cutoff OD al 492 11111 to separate scropositivc from
seronegativc samples was based on the mean plus or minus
two standard deviations (0.250) for lgG and on the mean plus
or minus three standard deviations (0.200) for lgM of normal
healthy controls. A single scrum dilution or 1/100 was used
for all samples tested.
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FIG. l. lgG ELISA results for ALA patients and controls. 
20hr+, Strong-positive AGDT result; 40hr+, weak-positive AGDT 
result; Neg, negative AGDT result. 
AGDT. The AGDT described elsewhere (9) was examined 
for the development of precipitin bands over a period of 48 h. 
Positivity of the AGDT (expressed at 20 or 40 h) indicates 
whcn prccipitin bands were observed. 
Statistical analysis. Data were analyzed by using the Pear­
son correlation coefficient and the Student I test. 
RESULTS 
A492 values obtained with the lgG and lgM ELISAs are 
shown in Fig. L 2, and 3. All healthy controls were sero­
negat ive by the lgG and lgM ELJSAs as well as by the 
AGDT. Nineteen of the twenty patients (95%) with ALA 
who had a positive AGDT on admission were also seropos­
itive by the lgG ELISA (Fig. 1), and for 18 (90%) the lgM 
ELISA gave positive results (Fig. 2). Two patients with 
ALA had a negative AGDT at the time of admission to the 
hospital; both of them proved to be seropositive by the lgG 
ELISA (Fig. 1), and for one the lgM ELISA was also 
positive (Fig. 2). There was a significant difference (P < 
0.001) in the OD values between ALA patients and normal 
healthy controls with the lgG and lgM ELISAs. No signifi­
cant difference was observed between the latter group and 
hospitalized patients with other diseases. 
The distribution of A492 values obtained with lgG and lgM 
ELISAs on sera obtained from asymptomatic subjects from 
an amoebiasis-endemic area are represented in Fig. 3. All 
culture-negative subjects were found to be scropositive by 
the lgG ELISA; notably, the highest A4n values were 
observed for the three subjects who were also positive by the 
AGDT. The lgM ELISA was positive for only one of the 
culture-negative controls. All five carriers of pathogenic 
zymodcmcs were scropositivc by the lgG ELISA; however. 
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FIG. 2. lgM ELISA results lor ALA patients and controls. 
20hr+, Strong-positive AGDT result; 40hr+, weak-positive AGDT 
result; Neg, negative AGDT result. 
ELISA. Only one of six sera from carriers of nonpathogcnic 
zymodcmes proved lo be positive by the lgM ELISA; of the 
three subjects who were lgG ELISA positive, two had a 
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FIG. 3. lgG and lgM ELISA results for healthy subjects from an 
amoebiasis-endemic area. No growth, Culture-negative subjects; 
Non-Path, carriers of nonpathogcnic 7.ymodcmcs; Path, carriers of 
pathogenic zymodemes. 
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clinical evidence of amoebiasis, two were positive by the 
lgG ELISA (Fig. 1) and one was positive by the lgM ELISA 
(Fig. 2). No significant differences in the OD values were 
observed between normal healthy controls and subjects from 
an endemic area with the lgM ELISA. However, significant 
differences in OD values were observed with the lgG ELISA 
between normal healthy controls and culture-negative con­
trols (P < 0.02) and between normal healthy controls and 
symptomless cyst passers of pathogenic (P < 0.001) and 
nonpalhogcnic (P < 0.05) zymodcmcs. There was an excel­
lent correlation between the lgG ELISA and the AGDT (r = 
0.96). The lgG and lgM ELISAs were found to have sensi­
tivities of 95 and 91 % and specificities of 91 and 95%, 
respectively, for the diagnosis of ALA. 
DISCUSSION 
Previously reported studies using the ELISA in the sero­
logical diagnosis of invasive amoebiasis have used poorly 
defined soluble antigens (2, 24, 26). More recently, highly 
antigenic membrane fractions of 27 lo 220 kilodaltons have 
been identified by using either monoclonal or polyclonal 
antibody probes (11, 15, 16, 19, 25). In particular, two such 
antigens arc recognized by the immune sera of ALA pa­
tients. One is a 170-kilodallon galaclose-N-acetyl galac­
tosaminc (Gal/Gal NAc)-inhibilablc Iectin, and the other is a 
90- to 96-kilodallon surface antigen which binds the Gal/Gal
NAc-inhibitable Icctin (11, 19, 25). The improved sensitivity
and specificity of the lgM ELISA in the serodiagnosis of
ALA in the present study was possibly due lo the detection
of specific IgM antibodies directed to epitopes on the surface
membrane which were not previously detected when a
crude, soluble E. histolytica extract was used as the antigen
(24).
Occasionally, the AGDT is negative on admission for 
ALA patient:;; this is thought to be due to inadequate 
antibody production, since the AGDT invariably becomes 
positive when repeated a few days after hospital admission 
(10, 13, 20). In other comparative serological studies, the 
ELISA was found to be positive on hospital admission in 
cases of ALA when other prccipitin tests were negative (12, 
23). This clinical advantage of the ELISA could be useful in 
the early diagnosis and treatment of ALA. 
The serological responses of asymptomatic subjects were 
interesting. The asymptomatic carriers of pathogenic zymo­
dcmes all produced lgG antibodies to the surface membrane 
of£. histolytica; however, the absence of an lgM response 
in them would indicate the chronicity of infection and the 
absence of deep tissue invasion. The specificity of the IgM 
ELISA for excluding deep tissue invasion is also indicated 
by the negative serological responses obtained from the sera 
of healthy carriers of nonpalhogenic zymodemes and cul­
ture-negative controls from the endemic area. The positive 
results obtained by the lgG ELISA for culture-negative 
controls and carriers of nonpathogenic zymodemes possibly 
indicates past infection with pathogenic zymodemes. Thus, 
while the IgG ELISA (like the AGDT) would be of impor­
tance in ascertaining the prevalence of pathogenic zymo­
dcmes in a community, inclusive of past and present infec­
tions, the specificity of the lgM ELISA would make it of 
value for diagnosing current tissue invasion . 
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CONCLUSIONS AND RECOMMENDATIONS 
The sensitivities and specificities of the IgG- and IgM­
enzyme-linked immunosorbent assays (ELISA) using soluble com­
plex antigen of Entamoeba histolytica were 99%/64% and 
92%/98%, respectively. The amoebic gel diffusion (AGDT) is 
as sensitive (91-100%) as the IgG-ELISA in the serodiagnosis 
of amoebic liver abscess (ALA). It is only with regard to 
the speed with which IgG-ELISA results are made available to 
the clinician that the ELISA has an advantage over the AGDT. 
Thus the IgG-ELISA like the AGDT, could be used to detect 
invasive amoebiasis, past and present, in the community. 
The IgM-ELISA was not sensitive enough (64%) to differentiate 




antigen of� histolytica improved the diagnostic 
of the IgM-ELISA by improving its sensitivity from 
91%. Thus the IgM-ELISA could prove valuable in 
differentiating past from current amoebic infection. Use of 
the plasma membrane antigen in the IgG-ELISA offered no 
added advantage over the soluble complex antigen which is 
less expensive and more easily prepared. To detect specific 
IgG-anti-Jh. histolytica antibodies, it is more economical to 
use the soluble complex antigen, whilst the detection of 
specific IgM-anti-Jh. histolytica would require the use of the 
102. 
plasma membrane antigen. 
The ability of the IgM-ELISA to differentiate between past 
and present infection needs to be further evaluated in a 
longitudinal study of patients with invasive amoebiasis in 
order to determine how soon after treatment IgM antibodies 
are not detected in the sera. 
Several investigators have demonstrated that the IgG-anti-E..,_ 
histolytica antibodies or total immunoglobulins recognised 
surface antigens of MW27 KDa-220 KDa (Mathews et al, 1986; 
Petri et al, 1987; Joyce and Ravdin, 1988; Torian et al, 
1989/1990 and Reed et al, 1989). Attempts to identify anti­
gens specific for IgM-anti-.E...... histolytica antibodies have not 
been performed. The observations recorded iri this disser-
tation indicate that such antigens are located on the plasma 
membrane of E..,_ histolytica. Because of the· improved sensit­
ivity of the IgM-ELISA with the plasma membrane, identifi­
cation, isolation and purification of these antigens is warr­
anted. Such investigations may constitute an important step 
in improving the serodiagnosis of invasive amoebiasis. 
The ELISA is a relatively cheap, simple, rapid and sensitive 
test. With the availability of purified antigens, it is 
highly likely that the ELISA may become the method of choice 
in the future. 
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